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Abstract
Lactobacilli are important members of the commensal microbiota of both man and animals, 
contributing to the health and well-being of the host. Several Lactobacillus strains are known 
to possess health-promoting characteristics, warranting their recognition as probiotics, defi ned 
by WHO as “live microorganisms which, when administered in adequate amounts, confer a 
health benefi t on the host”. Dietary supplementation with lactobacilli to enhance the health and 
productivity of the host has generated much interest in the production animal sector, especially 
aft er the prohibition of in-feed antimicrobials. In the swine rearing industry, disturbances in 
gastro-intestinal (GI) health, such as diarrhea, are very common, causing signifi cant fi nancial 
losses and compromising animal welfare. Th e use of lactobacilli as dietary probiotics to maintain 
and restore a balanced intestinal microbiota during various stressful situations, like the weaning 
of piglets, might help to prevent the development of GI infections. In addition to their use as 
probiotics, lactobacilli are also considered as good candidates for antigen carriers in vaccine 
applications. In particular, those strains carrying a surface (S) layer are attractive vaccine vectors, 
as the production of the antigenic epitope in each protein subunit as part of the S-layer lattice 
would enable the expression of a large number of antigens on the surface of the bacterial cell. Th is, 
in turn, would be expected to enhance the immune response generated by the vaccine. While the 
use of lactobacilli in a variety of ways to maintain and improve the health and productivity of 
swine has been widely examined, there are several aspects such as the selection process of the 
strains used as well as the functional mechanisms behind the observed eff ects that still remain to 
be clarifi ed. Th us, comprehensive studies regarding the use of lactobacilli as a probiotic and / or 
vaccine vector in various animal species are warranted.
Th e main aim of this work was to characterize the probiotic potential of lactobacilli for use 
in swine production, by using both in vitro and vivo methods. A total of 94 lactic acid bacterial 
(LAB) isolates, originating from porcine small intestine and feces, were fi rst screened for selected 
properties considered as important for putative probiotic microbes. In general, the isolates 
tolerated well low pH and bile, and showed highly variable adhesion capacities towards porcine 
enterocytes collected from fi ve diff erent intestinal sections. While the LAB isolates adhered more 
effi  ciently to large intestinal enterocytes, compared to those collected from the small intestine, 
the isolation site of the strain had no infl uence on the adhesion preferences of the strains towards 
enterocytes of diff erent origins. Th e spent culture fi ltrates collected from the isolates inhibited 
the growth of several intestinal pathogens. While this inhibition was mainly due to organic acids, 
some of the isolates appeared to produce also other inhibitory substances. Th e predominating 
phylotypes identifi ed among the isolates were Lactobacillus reuteri and Lactobacillus salivarius, of 
which the former generally had the best adhesion capacity, whereas the latter was one of the best 
inhibitors of pathogen growth. However, the properties assessed showed extensive variability, 
even between strains of the same species.
With respect to the porcine lactobacilli evaluated in the fi rst part of this work, six strains were 
selected for use in a multispecies bacterial supplementation, which was assessed in a feeding trial 
performed in recently weaned piglets. Additionally, a Lactobacillus strain possessing a surface 
(S) layer, namely Lactobacillus brevis ATCC 8287, was used in the feeding trial as a monostrain 
supplementation. While both supplementations did induce some alterations on the mRNA levels 
of selected cytokines in the intestinal mucosa, more pronounced eff ects were evident with the 
multispecies supplementation. Th e L. brevis supplementation induced a non-signifi cant increase 
in piglet body weight, but no such eff ect was observed for the multispecies supplementation. 
None of the supplemented strains could be isolated alive from feces, although the L. brevis strain 
was detected in the large intestinal digesta as well as in the mucosa of small and large intestines 
using techniques unable to diff erentiate between dead and live cells. Based on these results, it 
seems that the ability of these strains to survive and colonize within the porcine gut appears to 
be limited, although both types of supplementations exerted some immunomodulatory eff ects 
in the intestinal mucosa. While these supplementations may be suitable for use as probiotics 
in swine, additional studies will be needed to explore the eff ects of the strains on piglet health 
and immune status in more detail. Additionally, the suitability of the L. brevis strain for use as a 
vaccine vector will need to be further assessed.
In the fi nal part of this work, S-layer protein-carrying Lactobacillus amylovorus strains of 
swine origin, as well as the type strain (DSM 20531T) were characterized for certain probiotic 
properties. Additionally, the role of the S-layer proteins of each strain in adherence to IPEC-1 
cells was addressed. While none of the L. amylovorus strains adhered to porcine intestinal 
mucus, more variability was observed in their adherence to IPEC-1 cells, with some strains 
demonstrating a good adhesion capacity to these cells. Interestingly, the adhesion effi  ciency 
of the strains to IPEC-1 cells did not strictly correlate with their ability to inhibit adhesion 
of an Escherichia coli strain to the same cells. Th us, apart from competition for binding sites, 
other mechanisms are also involved in the ability of lactobacilli to inhibit pathogen adhesion. 
Th e extent of cytokine induction by the strains in human MoDC was of varying intensity, and 
did not clearly deviate towards Th 1 or Th 2 phenotypes. Instead, the induced cytokine response 
included Th 1 favoring (IL-12), Th 2 favoring (IL-10) as well as proinfl ammatory (TNF-α, IL-6, 
IL-1β, IP-10/CXCL10) cytokines. In all of the strains, one major S-layer protein (named SlpA) 
was recognized, and these proteins were found to share a high sequence similarity with the L. 
acidophilus NCFM SlpA protein. In addition, two of the strains carried additional S-layer like 
proteins on their surfaces (named SlpB and SlpC). Unexpectedly, none of the major S-layer 
proteins was found to solely mediate adhesion of the strains to IPEC-1 cells. 
List of original publications
Th is thesis is based on the following original publications referred to in the text by their Roman 
numerals (I-IV):
I Lähteinen T, Malinen E, Koort JMK, Mertaniemi-Hannus U, Hankimo T, Karikoski N, 
Pakkanen S, Laine H, Sillanpää H, Söderholm H and Palva A. (2010) Probiotic properties 
of Lactobacillus isolates originating from porcine intestine and feces. Anaerobe 16(3):293-
300.
II Lähteinen T, Lindholm A, Rinttilä T, Junnikkala S, Kant R, Pietilä TE, Levonen K, von 
Ossowski I, Solano-Aguilar G, Jakava-Viljanen M and Palva A. (2014) Eff ect of Lactobacillus 
brevis ATCC 8287 as a feeding supplement on the performance and immune function of 
piglets. Vet. Immunol. Immunopathol. 158(1-2):14-25
III Lähteinen T, Rinttilä T, Koort JMK, Kant R, Levonen K, Jakava-Viljanen M, Björkroth J and 
Palva A. Eff ect of a multispecies Lactobacillus formulation as a feeding supplement on the 
performance and immune function of piglets. (Submitted) 
IV Hynönen U, Kant R, Lähteinen T, Pietilä TE, Beganović J, Smidt H, Uroić K, Åvall-
Jääskeläinen S, Palva A. (2014) Functional characterization of probiotic surface layer 
protein-carrying Lactobacillus amylovorus strains. BMC Microbiol. 14(1):199 doi: 
10.1186/1471-2180-14-199
Th e original publications are reprinted with the kind permission of the publishers. 
In addition, some unpublished results are presented.
Abbreviations
ADWG Average daily weight gain
ATCC American Type Culture Collection
AUC Area under the growth curve
ARP Area reduction percentage
BMDC Bone marrow derived dendritic cell
BSA Bovine serum albumin
CD Cluster of diff erentiation
cDNA Complementary deoxyribonucleic acid
CFU Colony forming units
CXCL (C-X-C motif) ligand
CTLA Cytotoxic T-lymphocyte antigen
CWF Cell wall fragment
DAPI 4’, 6-diaminido-2-phenylindole dilactate
DC Dendritic cell
DC-SIGN Dendritic cell specifi c C-type lectin intercellular adhesion molecule 
 3-grabbing non-integrin 
DFI Daily feed intake
DMEM Dulbecco’s modifi ed eagle medium
DMSO Dimethyl sulphoxide
DNA Deoxyribonucleic acid
DSM Deutsche Sammlung von Mikroorganismen
ECM Extracellular matrix
EFSA European Food Safety Authority
EHEC Enterohemorrhagic Escherichia coli
ELISA Enzyme-linked-immunosorbent-assay
ETEC Enterotoxigenic Escherichia coli
FAO Food and Agriculture Organization of the United Nations
FCR Feed conversion ratio
FCS Fetal calf serum
FEEDAP Panel on Additives and Products or Substances used in Animal Feed
FISH Fluorescence in situ hybridisation
GI Gastrointestinal
GM-CSF Granulocyte macrophage-colony stimulating factor 
HBSS Hanks balanced salt solution
HCl Hydrochloric acid
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HPRT1 Hypoxanthine phosphoribosyltransferase 1
HRP Horse radish peroxidase
IEC Intestinal epithelial cell




IL-12-RB2 Interleukin 12 receptor beta 2 subunit
IP Interferon gamma-induced protein
ISR 16S-23S intergenic spacer region
kDa Kilodalton
LAB Lactic acid bacteria
LB Luria Bertani medium
MIC Minimum inhibitory concentration 
MoDC Monocyte derived dendritic cell
MOI Multiplicity of infection
MPN Most probable number
mRNA Messenger ribonucleic acid
MRS de Man Rogosa Sharpe medium
MyD-88 Myeloid diff erentiation primary response gene 88
NaOH Sodium hydroxide
NF-?B Nuclear factor ?B
OD Optical density
PAGE Polyacrylamide gel electrophoresis
pBD Porcine beta-defencin 
PBMC Peripheral blood mononuclear cell
PBS Phosphate buff ered saline
PCR Polymerase chain reaction
PFGE Pulsed-fi eld gel electrophoresis
pI Isoelectric point
PPIB Peptidyl-prolyl cis-trans isomerase B
qPCR Quantitative polymerase chain reaction
QPS Qualifi ed presumption of safety
RNA Ribonucleic acid
RPL32 Ribosomal protein L32
rpm Revolutions per minute
rRNA ribosomal ribonucleic acid
SDS Sodium dodecyl sulphate
S-layer Surface layer
SCF Spent culture fi ltrate
Slp Surface layer protein
Th  T helper cell
Treg Regulaory T cell
TEER Transepithelial electric resistance
TGF Transforming growth factor
TLR Toll-like receptor
TNF Tumor necrosis factor
TSA Tryptic soy agar
TSB Tryptic soy broth
UPGMA Unweighted pair group method with arithmetic averages 
WGS Whole genome sequencing
WHO World Health Organization
11 Introduc? on
Th e main aim of livestock farming is to produce safe foodstuff s for human consumption. 
While the importance of animal health and welfare is being increasingly appreciated in animal 
production, the intensive management practices of modern animal farming oft en subject the 
animals to severe stress, leading to health problems and reduced productivity. For example, 
diarrhea and other disturbances in gastro-intestinal (GI) health are very common in the swine 
rearing industry, where they are responsible for signifi cant fi nancial losses and compromised 
animal welfare (Reid and Friendship, 2002). In addition to direct health problems to the host 
animal, pathogenic bacteria can also be transferred along the food chain, thus endangering 
also human health. In an attempt to manage the problems caused by GI and other infections, 
sub-therapeutic levels of antibiotics have long been incorporated into animal feed (Dibner 
and Richards, 2005); this both eff ectively promotes the growth of the animals and reduces 
animal mortality and morbidity (Cromwell, 2002). However, the worldwide concern about 
the growing problem of antibiotic resistance and about the transfer of resistance genes from 
animal to human microbiota (Aarestrup, 2002) has led to a gradual discontinuation of growth-
promoting antibiotics throughout Europe. For example, Sweden prohibited the use of antibiotic 
feed additives in 1986 (Wierup, 2001), Denmark in 2000 (Aarestrup et al., 2010), and from the 
beginning of 2006, this prohibition has been implemented throughout the European Union. 
Aft er the withdrawal of these antibiotics, increases in mortality and morbidity, especially due 
to enteric infections, have been reported in pig farms (Callesen, 2002; Casewell et al., 2003). 
Additionally, the use of antibiotics as therapeutic agents has increased (Callesen, 2002; Casewell 
et al., 2003). Although these negative consequences on the pig production may be only transient 
(Aarestrup et al., 2010), it is clear that alternative ways are urgently needed to promote the health 
of production animals and to reduce the increasing use of therapeutic antibiotics. 
Various dietary strategies have been claimed to improve gut health and disease resistance 
of production animals, including swine (Roselli et al., 2005; Th acker, 2013). One such approach 
involves the supplementation of animal feeds with benefi cial microbes. Th e concept that harmful 
gut microbes could be suppressed and displaced by benefi cial ones to improve the health of the 
host fi rst appeared over a century ago. Since then, the concept of benefi cial microbes, which 
are oft en called “probiotics”, has evolved considerably, as have the defi nition for these microbes 
(Isolauri et al., 2002; Dobrogosz et al., 2010). According to the World Health Organization, 
probiotics are defi ned as “live microorganisms which, when administered in adequate amounts, 
confer a health benefi t on the host” (WHO/FAO, 2001). 
One of the health benefi ts associated with probiotic consumption is modifi cation of the 
gastro-intestinal (GI) microbiota in such a way that there is increased resistance to colonization 
by pathogenic bacteria (McCracken and Gaskins, 1999; Lalles et al., 2007; Ohashi and Ushida, 
2009). Th e commensal GI tract microbiota is a highly complex community, consisting of an 
immense number of diff erent species of microbes. In humans, the gut microbiota has generally 
been estimated to consist of around 500-1000 diff erent microbial species (Yatsunenko et al., 
2012), and estimations of the species diversity of swine intestinal microbiota have been in 
the same range (Leser et al., 2002; Lamendella et al., 2011). Th e gut microbiota is of crucial 
importance to the host, for example providing protection against extrinsic microbes. Th is is 
emphasized by the fact that germfree animals, devoid of commensal microbiota, are much more 
susceptible to infections, especially to gastro-intestinal infections. For example, the lethal dose 
of Salmonella enteritidis in a germfree mouse is as low as ten bacteria delivered per os, whereas 
Introduction
2in conventional mice 109 bacteria are required to evoke a lethal infection (Collins and Carter, 
1978). Th e colonization resistance provided by the commensal intestinal microbiota is illustrated 
also by studies conducted with newly hatched chickens. In commercial poultry settings, the 
development of the commensal gut microbiota during the fi rst weeks of life is delayed, e.g. 
rendering the hatchlings highly vulnerable to Salmonella infections (Schneitz, 2005). However, 
providing the gut contents of an adult bird to the chicks has been shown to be a very eff ective 
way to protect the young birds against Salmonella, and other intestinal infections (Nurmi and 
Rantala, 1973; Schneitz, 2005; Dobrogosz et al., 2010), and this phenomenon is referred to as 
“competitive exclusion” (CE). In other production animals, the development of the commensal 
microbiota aft er birth is not as prone to disturbances as it is in poultry, and thus the practice of 
CE is not as widespread elsewhere. However, probiotic products containing defi ned bacterial 
strains and aimed at increasing the disease resistance of the animals are being used also in several 
other species, including swine (Bernardeau et al., 2006; Gaggia et al., 2010).
Several diff erent types of microbes, i.e. bacteria, yeasts and molds, have been evaluated 
as animal probiotics, but the genus Lactobacillus has been one of the most widely applied 
genera (Nousiainen et al., 2004; Gaggia et al., 2010). Lactobacilli are prominent members of 
the commensal intestinal microbiota of both humans and animals, and are considered to be 
benefi cial for the host. In piglets, a reduction in the abundance of intestinal lactobacilli has been 
observed to occur around weaning (Konstantinov et al., 2006a; Su et al., 2008b) and this decline 
has been considered to predispose the piglets to GI disturbances, e.g. diarrhea. Th e restoration 
of a balanced gut microbiota aft er the application of probiotic microbes could help to prevent 
the development of GI infections around weaning. Indeed, positive health eff ects including 
reductions in diarrhea prevalence have been described in swine aft er consumption of lactobacilli 
and other probiotics, although positive eff ects have not been detected in all studies that have 
been performed (Nousiainen et al., 2004; Lalles et al., 2007; Bosi and Trevisi, 2010; Kenny et 
al., 2011). Th e functional mechanisms behind the putative health-promoting eff ects of probiotic 
lactobacilli are for the most part unclear. Consequently, research aimed at revealing the putative 
positive health eff ects of probiotic consumption as well as the molecular mechanisms leading to 
these outcomes is very important and can be used to guide the selection of bacterial strains used 
in probiotic feed additives intended not only for swine but also for other animals.
Introduction
32 Literature review
2.1 The gastrointes? nal tract of swine
Th e digestive tract of swine is classifi ed as monogastric and shares many anatomical and 
physiological similarities with the human GI-tract (Miller and Ullrey, 1987; Heinritz et al., 2013). 
Anatomically the porcine GI-tract can be divided into four parts: the esophagus, the stomach, 
the small intestine (which is further divided into the duodenum, the jejunum and the ileum) as 
well as the large intestine (which is further divided into the cecum, the colon and the rectum; 
Figure 1). At the time of birth, the lengths of the porcine small and large intestine are around 
four and one meters, respectively, while at maturity the corresponding measures lie in the range 
from 18 to 23 meters and four to seven meters (McCance, 1974; Miller and Ullrey, 1987). 
Similarly to humans, pigs are omnivorous colon fermenters. However, while humans lack 
a distinct cecum, pigs exhibit also signifi cant cecal fermentation. Th is diff erence is illustrated 
by the fact that the short chain fatty acids (SCFA) produced by the large intestinal microbiota 
of swine may provide up to 30% of the host energy requirements for maintenance (Rerat et al., 
1987), whereas in humans only about 10% of this requirement is provided by SCFA produced in 
the colon (Bergman, 1990). Th e diet of feral pigs is very diverse, consisting mainly of vegetation 
like fruits, grasses, forbs, corn, roots and tubers, but also of animal matter including both 
invertebrates and small vertebrates (Baber and Coblentz, 1987; Taylor, 1999). In commercial pig 
production, a highly palatable and concentrated feed is provided to maximize growth effi  ciency; 
the main ingredients in swine fodder are diff erent grains like maize and barley and various 
sources of proteins such as soybean and fi sh meal as well as whey powder. 
Like in all mammals, the GI microbiota of swine is a highly complex community consisting 
mainly of bacteria, but also of archae and eukaryotic microbes as well as viruses. Th e total 
number of microbial cells in the GI tract is estimated to be around 1014 cells, which is ten 
times more than the number of cells of the host organism (Luckey, 1972; Savage, 1977). Th e GI 
microbiota is crucial for the health and normal development of the host; it provides resistance to 
colonization by harmful microbes, infl uences intestinal structure and physiology and promotes 
the development of the immune system (reviewed by Shanahan (2002)). In general, the GI-tract 
microbiota of swine resembles that of humans; e.g. the predominant phyla in both of these 
host species are Firmicutes and Bacteroidetes (Mahowald et al., 2009; Isaacson and Kim, 2012; 
Heinritz et al., 2013). However, there are some interesting diff erences between the intestinal 
microbiota of swine and of humans. For example, LAB and in particular lactobacilli, are among 
the most abundant phylotypes in the gut microbiota of swine, while in the human intestine, 









Figure 1. A schematic representation of the GI-tract of swine
42.2 The genus Lactobacillus
2.2.1 Overview 
Th e genus Lactobacillus is an important group of LAB belonging to the phylum Firmicutes. 
Members of the genus Lactobacillus are Gram-positive rod shaped bacteria that obtain the 
energy they need for the maintenance and macromolecule synthesis from substrate-level 
phosphorylation (i.e. fermentation), forming lactic acid as the primary metabolic end product. 
Th is highly heterogeneous genus consists of over 150 species inhabiting diverse ecological 
niches. Lactobacilli are ubiquitous in natural environments and are present in all places where 
substrates rich in carbohydrates are available, i.e. in soil, sewage and plant material. Lactobacilli 
are also essential members of the commensal microbiota of humans and animals, e.g. they can 
be found in the GI tract and are present in feces of several diff erent host species. For centuries, 
lactobacilli have been used as starter cultures in the production of fermented foods, particularly 
in dairy products, but also in vegetable and meat products. In addition to foods intended for 
human consumption, Lactobacillus fermentation can also be used to produce animal feeds, such 
as silage (Holzer et al., 2003; Meieregger et al., 2011).  Furthermore, as lactobacilli have been 
associated with various health-promoting properties, they are widely used as probiotics for both 
humans and animals (Barrangou et al., 2012).
Two basic fermentative pathways are utilized by lactobacilli. Th e homofermentative pathway 
(Embden-Meyerhof-Parnas pathway) produces almost exclusively lactic acid as the end product, 
whereas in the heterofermentative pathway (phosphoketolase pathway) also CO2 and ethanol 
are produced. Based on these pathways, lactobacilli can be divided into three distinct groups; (1) 
obligatory homofermentative species, (2) facultative heterofermentative species, which can use 
both of the pathways, and (3) obligatory heterofermentative species (Hammes and Hertel, 2009). 
Th e various environmental habitats of lactobacilli are refl ected in the high genomic diversity 
of the genus. Th e size of the Lactobacillus genome ranges usually from 1.8 to 3.3 Mbp (Canchaya 
et al., 2006; Kant et al., 2011a; Lukjancenko et al., 2012), the smallest reported so far being that 
of Lactobacillus iners which is only 1.3 Mbp (Macklaim et al., 2011). Th e G+C content of the 
Lactobacillus genomes is typically low (Barrangou et al., 2012) but also diverse, ranging from 32% 
to 55% (Axelsson, 2004). Th e taxonomy of lactobacilli is known to be complex and constantly 
changing; the information obtained from new studies and the recent availability of whole genome 
sequences (WGS) have enabled more conclusive analyses of the phylogenetic relationships of 
lactobacilli species (Makarova et al., 2006; Claesson et al., 2008; Kant et al., 2011a). It is evident 
that the phylogeny of lactobacilli species does not correlate well with their phenotypes (Felis and 
Dellaglio, 2007), and further revisions of the taxonomy have been proposed (Axelsson, 2004; 
Makarova et al., 2006).
2.2.2 Lactobacilli in the gut microbiota of swine
At birth, the sterile environment of the womb changes to a situation in which there is a constant 
microbial exposure, leading to colonization of the newborn animal. Th e establishment of the 
host microbiota proceeds sequentially, as a succession of microbial populations, until a relatively 
stable climax community is formed (Savage, 1977; Isaacson and Kim, 2012). In most suckling 
animals, lactobacilli are one of the fi rst colonizers of the gut (Savage, 1977; Berg, 1996), and 
this has been confi rmed in swine as well (Smith, 1965; Fuller et al., 1978; Ducluzeau, 1983; 
Konstantinov et al., 2006a). Th e colonizing bacteria, including lactobacilli, originate from the 
rearing environment, like maternal feces (Tannock et al., 1990; Nousiainen et al., 2004). Th e 
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in several studies (Kenworthy and Crabb, 1963; Tannock et al., 1990; Swords et al., 1993; Naito 
et al., 1995; Melin et al., 1997; Konstantinov et al., 2004b; Konstantinov et al., 2006a), although 
the experiments have been generally conducted using culture-based methods, which are unable 
to detect the majority of gut microbes (Vaughan et al., 2000). Substantial individuality in the 
colonization process of the piglet intestine has been described during the fi rst two weeks of life, 
this being refl ected by diff erences in the gut microbiota of littermates and penmates (Th ompson 
et al., 2008). In addition, the developing microbiota of piglets is infl uenced also by management 
practices (Davis, 2012). 
During the suckling period, the numbers of lactobacilli in the ileum of piglets seem to remain 
rather constant (Konstantinov et al., 2006a), but marked changes in both the abundance and 
community structure of lactobacilli occur at weaning. Weaning, which occurs at approximately 
three to four weeks of age in commercial swine production units, exposes the piglets to severe 
social, environmental and nutritional stresses. Th e weaning transition causes a signifi cant 
decrease in the overall GI tract Lactobacillus population (Franklin et al., 2002; Konstantinov et 
al., 2006a; Pieper et al., 2006; Su et al., 2008a), and changes in the diversity and structure of 
lactobacilli community have also been described (Bateup et al., 1998; Janczyk et al., 2007; Su et 
al., 2008a). However, at least some of these changes are transient (Janczyk et al., 2007).
Investigations of the GI tract microbial composition of post-weaning swine conducted with 
high-throughput molecular techniques have revealed lactobacilli as being among of the most 
abundant phylotypes recognized in the intestine (Pryde et al., 1999; Leser et al., 2002; Hill et al., 
2005) and feces (Kim et al., 2011). Th e cell count of lactobacilli in the porcine intestine, based 
on bacterial culture and fl uorescent in situ hybridization (FISH), is at the level of 108 CFU per 
gram of digesta (Konstantinov et al., 2004a; Castillo et al., 2006). Th e predominant Lactobacillus 
species in the swine intestine include e.g. L. amylovorus, L. reuteri, L. johnsonii, L. mucosae 
and L. salivarius (Leser et al., 2002; Hill et al., 2005; Konstantinov et al., 2006a; Mann et al., 
2014).  Although the GI tract microbiota of adult swine is relatively stable over time, dietary and 
environmental factors can induce changes in the composition of the microbiota, including the 
lactobacilli community (Fuller, 1989; Bauer et al., 2006; Rist et al., 2013).
2.2.3 Lactobacilli as animal probio? cs
Th e lactobacilli in the GI tract have long been considered as being benefi cial for the host (Tannock, 
1990), and several species of lactobacilli are known to possess properties considered important 
for probiotic microbes (Reid, 1999). Consequently, the oral supplementation of these bacteria 
is hypothesized to improve the gut health of the host (Fuller, 1989; Meieregger et al., 2011), and 
the use of lactobacilli as probiotics for both man and animals has been extensively studied in the 
last decades (Simon et al., 2001; Nousiainen et al., 2004; Bernardeau et al., 2006; de Vrese and 
Schrezenmeir, 2008; Turpin et al., 2010). Although the use of microbial feed supplements for 
farm animals was explored as early as 1925, this practice was not exploited commercially until 
the 1960s and 1970s, coinciding with increased concerns over the widespread and uncontrolled 
use of antibiotic growth promoters (Fuller, 1999; Reid and Friendship, 2002; Meieregger et al., 
2011).  In swine, L. acidophilus was one of the fi rst microbes reported to stimulate the growth 
when supplemented into the feed (King, 1968). Currently, around 20 diff erent species of microbes 
are authorized in the EU as feed additives for animal nutrition, including several Lactobacillus 
species, such as L. brevis, L. plantarum, L. rhamnosus and L. salivarius (EU, 2014).
Literature review
6Several health eff ects have been proposed for benefi cial microbes, but as the goals of 
probiotic consumption depend on the target host species, some of these are not relevant in 
the veterinary fi eld, or at least not in production animals (Table 1). On the other hand, some 
eff ects desirable in production animals may be irrelevant or even unwanted in humans. Th ese 
include e.g. increased body weight gain and improvements in feed effi  ciency (Simon et al., 2001; 
Bernardeau and Vernoux, 2013). In addition to benefi cial eff ects for the host animal itself, one 
further aim of using probiotic microbes in production animals would be to reduce the carriage of 
microbes which are not harmful to the hosts themselves, but can lead to human infection if they 
pass in to the food chain (Reid and Friendship, 2002; Doyle and Erickson, 2012). 
Th e mechanisms behind the health enhancing eff ects of probiotics are largely unknown, but 
several modes of action have been proposed (reviewed by Fooks and Gibson (2002); Vanderpool 
et al. (2008); Ohashi and Ushida (2009) and Kenny et al. (2011)). Th ese include e.g. 1) eff ects on 
intestinal microbiota, such as stimulation of indigenous lactobacilli or other benefi cial bacteria, 
2) inhibition of harmful microbes via competition for nutrients or receptors for adhesion, or via 
production of antagonistic substances, 3) stimulation and / or modulation of the host immune 
function, 4) regulation of enterocyte functions, like the maintenance of the epithelial barrier  5) 
stimulation and / or modulation of intestinal nutrition physiology, like absorption and secretion 
activity, or enhancement of short-chained fatty acid (SCFA) production.
Table 1. Proposed health eff ects of probiotics and their relevance in the veterinary fi eld, as 
estimated by the author.
Proposed eff ect (adapted from de Vrese and Schrezenmeir (2008) and  
Chassard et al. (2011)
Relevance in veterinary 
medicine
Very well-established eff ects with valid scientifi c proof
Prevention and alleviation of certain types of diarrhea (e.g. rotavirus, 
antibiotic-associated, traveler’s)
High
Alleviation of lactose intolerance Low
Well-established eff ects / eff ects observed in certain target groups
Modulation of the microbiota (usually intestinal) High
Immunomodulation / - regulation High
Prevention of respiratory tract infections High
Benefi cial eff ects in infl ammatory diseases of the GI tract (e.g. 
infl ammatory bowel disease, bacterial overgrowth)
Intermediate (mainly 
comp. animals1)
Prevention and alleviation of allergies / atopic diseases in infants Intermediate (mainly 
comp. animals)
Treatment of urogenital infections Intermediate (mainly 
comp. animals)
Eff ects not well-established with insuffi  cient scientifi c proof
Normalization of passing stool and stool consistency (e.g. constipation) Intermediate (mainly 
comp. animals)
Alleviation of autoimmune diseases Intermediate (mainly 
comp. animals)
Prevention of cancer Intermediate (mainly 
comp. animals)
Prevention of ischemic heart disease Low
Reducing of blood cholesterol Low
Caries prevention Intermediate (mainly 
comp. animals)
1 companion animals 
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In addition to the use of lactobacilli as probiotics, interest in their use as delivery vectors for 
vaccine antigens has increased during the last decades (Bermudez-Humaran et al., 2011; Wells, 
2011a). Many of the properties considered important for probiotics (see section 2.2.1.) also apply 
to the use of bacteria as potential vaccine delivery vectors, thus several Lactobacillus species are 
good candidates for both applications (Mercenier, 1999). 
One important advantage of using live bacterial vaccine vectors would be the ability 
to administer these vaccines mucosally, e.g. per os. Mucosal administration is expected to 
generate improved and more appropriate local immune response than the traditional parenteral 
route, giving better protection against infectious agents that mostly enter the body mucosally 
(Mercenier, 1999; Fujkuyama et al., 2012). In addition, mucosal administration is more 
convenient and cheaper than the parenteral route (Mercenier, 1999; Holmgren et al., 2003). 
Traditionally, certain pathogenic bacteria, e.g. Salmonella and Listeria, have been extensively 
investigated for use as vaccine vectors (Detmer and Glenting, 2006; Mohamadzadeh et al., 2008), 
but the comparatively lower intrinsic immunogenicity of lactobacilli compared to attenuated 
pathogens is considered favorable, since it may result in fewer side-eff ects in the vaccinated host 
(Pouwels et al., 1998; Mercenier, 1999; Wells and Mercenier, 2008). At the same time, however, 
lactobacilli are able to stimulate and / or modulate host immune responses, as demonstrated 
by several studies performed in both humans and animals (reviewed by Corthesy et al. (2007) 
and Wells (2011b)). Th is adjuvant-like property has been demonstrated during infections, e.g. 
as increased pathogen-specifi c Ig-titers (Link-Amster et al., 1994; Kaila et al., 1995; Vlasova 
et al., 2013), and also as enhancement or modulation of the immune response stimulated by 
vaccination (Licciardi and Tang, 2011; Maidens et al., 2013). However, studies performed on 
pigs are extremely scarce; one study examining the eff ect of L. rhamnosus supplementation on 
porcine reproductive and respiratory syndrome (PRRS) vaccination could not detect any impact 
on the resulting immune response (Kritas and Morrison, 2007). 
Th e Lactobacillus species mostly explored as vaccine vectors include L. plantarum, L. casei, 
L. helveticus and L. acidophilus (Wells, 2011a). Various antigens have been successfully expressed 
in lactobacilli (Mohamadzadeh et al., 2008; Wells, 2011a), including also those originating from 
pathogens infecting swine, e.g. transmissible gastroenteritis virus (Ho et al., 2005), classical swine 
fever virus and porcine parvovirus (Xu et al., 2011). In addition, lactobacilli have been investigated 
as carriers for DNA vaccines (Li et al., 2007). Most of the immunization studies performed with 
recombinant lactobacilli have been conducted in mouse models (Mohamadzadeh et al., 2008; 
Wells, 2011a), but promising results have been obtained also in swine (Xu et al., 2011). 
2.2.5 Surface layer proteins of lactobacilli
Surface (S) layers are cell envelope structures found on the outermost surface of many bacteria and 
most archaea, completely covering the cells (Sleytr et al., 2014). In addition, several Lactobacillus 
species including e.g. L. amylovorus, L. crispatus, L. acidophilus, L. brevis and L. helveticus are 
known to possess an S-layer (Hynönen and Palva, 2013). Th ese crystalline bidimensional arrays 
are composed of identical protein or glycoprotein subunits assembled to form a regular porous 
structure, which can be aligned in square, oblique or hexagonal symmetry, although only the last 
two of these possible arrangements have so far been observed in S-layers of lactobacilli (Åvall-
Jääskelainen and Palva, 2005). Th e S-layer proteins of lactobacilli are among the smallest known, 
with molecular weights ranging from 25 to 71 kDa (Hynönen and Palva, 2013), while in other 
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8bacterial species the size of these proteins is much larger, up to 200 kDa (Sara and Sleytr, 2000). 
Th e thickness of the S-layer is generally 5-20 nm, and the size of the pores, which occupy 30% 
to 70% of the S-layer surface, is in the range of approximately 2-8 nm (Sleytr et al., 2014). Th e 
sequence similarities between S-layer proteins of diff erent bacterial species are generally low 
(Sleytr et al., 2014), and this is the case also in lactobacilli; homology is found only between genes 
of related species (Hynönen and Palva, 2013). Despite this, some common features are present 
in the amino acid composition of S-layer proteins, such as their high content of hydrophobic 
amino acids as well as the low amount of sulfur containing amino acids (Sleytr et al., 2014). 
A characteristic which is specifi c to lactobacillar S-layers is the higher abundance of positively 
charged amino acid residues compared to that of negatively charged residues, leading to high 
theoretical isoelectric point (pI) values (i.e. 9.35-10.4) (Åvall-Jääskelainen and Palva, 2005).
Th e S-layer subunit proteins attach to each other and to the underlying cell wall structures 
by non-covalent interactions. It is possible to achieve complete detachment of the S-layer and 
disintegration into the monomer subunits e.g. with high concentrations of chaotropic agents 
disrupting the interactions of non-covalent forces (Sleytr et al., 2014). Isolated S-layer protein 
subunits have a high intrinsic propensity to recrystallize into regular lattices e.g. on solid supports 
or even in suspension aft er the removal of the disrupting agent, thus they are very poorly water-
soluble. Two distinct structural regions have been identifi ed in S-layer proteins; the fi rst being 
involved in the binding of the S-layer to the cell wall, and the other being responsible for the 
S-layer assembly (Sleytr et al., 2014). Th e locations of these regions in the S-layer protein vary 
between diff erent species of lactobacilli (Hynönen and Palva, 2013). 
Although no common biological role for S-layers has been identifi ed, various functions 
have been postulated, including protection from environmental factors, cell shape maintenance, 
binding or sieving of large molecules and modulation of the host immune responses (Hynönen 
and Palva, 2013; Sleytr et al., 2014). In addition, mediation of adhesion to host structures has 
commonly been proposed as a function of lactobacillar S-layers. Attempts to produce completely 
S-layer negative Lactobacillus mutants have been unsuccessful (Boot et al., 1996a; Martinez et 
al., 2000; Palva A. unpublished results), emphasizing the necessity of this structure for its host 
cell. For this reason, protein level methods (e.g. labelled subunits or recombinantly expressed 
proteins) have to be used when examining the role of S-layers in bacterial adhesion. In some 
Lactobacillus species, S-layers have been shown to mediate the adhesion to diff erent targets, like 
extracellular matrix (ECM) proteins and epithelial cells (Mobili et al., 2010; Hynönen and Palva, 
2013). 
Th e structural properties of the S-layer, as well as the self-assembly tendency of the subunits 
mean that these structures are attractive candidates for a wide range of applications, including 
vaccine carriers. Th e ability to produce the antigenic epitope in each S-layer subunit as part of 
the overall lattice structure would enable bacteria with such chimeric S-layers to display a large 
number (e.g., ~5×105/bacterium) of antigenic molecules on their cell surface (Sleytr et al., 2007). 
Small model peptides have already been successfully expressed in each monomeric subunit of 
the S-layer of L. brevis ATCC 8287 (Åvall-Jääskeläinen et al., 2002) and L. acidophilus ATCC 
4356 (Smit et al., 2002). In the future, increasing knowledge about the structure and biology 
of Lactobacillus S-layers will help in the utilization of these structures in the development of 
effi  cient vaccines for veterinary use.
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92.3 Discovering probio? c microbes
2.3.1 How to choose the best strains?
Th e vast species and strain diversity of lactobacilli and other potentially benefi cial microbes 
ensures that there is no shortage of candidate probiotics. However, as it is impossible to test 
large numbers of diff erent strains in in vivo feeding trials, some kind of preliminary selection is 
necessary. Th e commonly stated selection criteria for probiotic microbes involve several features 
related to safety aspects as well as functional and technological properties (Table 2). 
Th e fi rst step in the development of a probiotic product is the isolation of the candidate 
strain(s). Th e origin of the strain is an important factor to be considered, e.g. for human 
probiotics, strains of human origin are preferred (Collins and Gibson, 1999; Saarela et al., 2000; 
Ouwehand et al., 2011). It has been claimed that at least some of the functional properties of 
probiotics, such as adhesion to the intestinal epithelium, are host species specifi c, indicating that 
strains isolated from the intended target species would show better performance as compared 
to those isolated from other species (Bengmark, 1998; Saarela et al., 2000). However, the results 
of in vitro studies assessing the host specifi city of lactobacilli adherence have been confl icting, 
with both supporting fi ndings (Fuller, 1973; Barrow et al., 1980; Mäyrä-Mäkinen et al., 1983; 
Nemcova et al., 1997), as well as negative reports (Rinkinen et al., 2000; Nikoskelainen et al., 
2001; Rinkinen et al., 2003). Nevertheless, since host species specifi c diversifi cation of lactobacilli 
strains has been observed (Oh et al., 2010; Frese et al., 2011; Guinane et al., 2011), it appears 
prudent to prefer strains originally isolated from the target species.
Safety is obviously one of the most important requirements for a possible probiotic (Saarela 
et al., 2000; von Wright, 2005; Chassard et al., 2011). While lactobacilli have a long history of 
safe use in food products, they are living micro-organisms, and theoretically could be capable 
of evoking unwanted side-eff ects, at least in susceptible individuals. As reviewed by Bernardeau 
et al. (2006) and Sanders et al. (2010), cases of lactobacillar infections, e.g. bacteremia, 
peritonitis and pneumonia, have been reported in humans, but considering the huge quantities 
of probiotic products consumed, these infections seem to be extremely rare occurring mainly 
in immunocompromised patients. On the other hand, as far as the author is aware, there are 
no reports of animal infections caused by lactobacilli, even though Weissella confusa (basonym 
Lactobacillus confusus) has been isolated from an otitis sample obtained from a dog (Björkroth 
et al., 2002) as well as from a case of systemic infection in a mona monkey (Cercopithecus 
mona) (Vela et al., 2003). With respect to the assessment of safety, an unequivocal taxonomic 
identifi cation of the strain is an important prerequisite (WHO/FAO, 2002; Vankerckhoven et al., 
2008), as a number of bacterial species, including several lactobacilli, have received a qualifi ed 
presumption of safety (QPS) status in the European Union (EFSA, 2007). Micro-organisms to 
be used as feed additives are authorized according to the European Parliament and Council 
Regulation (EC) No 1831/2003, and this protocol requires thorough safety assessment, including 
toxicity studies performed using the target species (von Wright, 2005; Anadón et al., 2006; 
Meieregger et al., 2011). However, a full safety assessment is required only for strains without a 
QPS status (Meieregger et al., 2011; Salminen and von Wright, 2012). 
Although non-viable microbes have demonstrated some health enhancing eff ects 
(Ouwehand and Salminen, 1998), it is generally assumed that viability is important for the 
functional properties of probiotic microbes (Chassard et al., 2011; Ouwehand et al., 2011). 
Consequently, the candidate strain has to be able to survive industrial manufacturing conditions, 
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as well as to maintain high viable cell numbers in the fi nal product during storage (Saarela et al., 
2000; Meieregger et al., 2011). Th is requirement makes the technological properties of the strain 
(Table 2) extremely important in the selection process, and it has been claimed that the current 
probiotics have been chosen mostly based on these characteristics (Lacroix and Yildirim, 2007). 
For the most part, probiotics of intestinal origin are highly sensitive to many environmental 
stresses, such as the extremes of temperature, oxygen stress and the mechanical shearing forces 
encountered during industrial processing (Lacroix and Yildirim, 2007; Meieregger et al., 2011), 
Th ese are factors which pose signifi cant challenges to the process optimization. Moreover, in 
addition to aff ecting the cell yield and viability of the strain, manufacturing procedures and 
also the food matrix into which the bacteria are to be incorporated may have an infl uence on 
the functional properties of the strain (Pessi et al., 1998; Deepika et al., 2009; Grzeskowiak 
et al., 2011; Deepika et al., 2012), further emphasizing the importance of the optimization of 
production process.
It is important to recognize that the characteristics of a bacterial strain are specifi c to that 
particular strain, meaning that even strains belonging to the same species can have divergent 
properties (Pineiro and Stanton, 2007; Marteau, 2011). Th us, properties known to exist in one 
strain cannot be extrapolated to all strains of the same species. Consequently, appropriate in vitro 
and in vivo experiments need to be performed for each candidate strain to guide the selection 
process, and the fi nal validation of the health benefi ts can only be obtained in carefully controlled 
clinical trials (Chassard et al., 2011).
Table 2. Commonly used criteria for selection of probiotic microbes. Adapted from Saarela et al., 
(2000); Chassard et al., (2011); Meieregger et al., (2011)
Safety aspects Functional properties Technological properties






Toxicity (e.g. acute and 
chronic)











Favorable / no adverse eff ects 
on product quality
2.3.2 In vitro studies
2.3.2.1 Tolerance of low pH and bile
Probiotics are usually consumed orally, and their expected biological functions occur in the 
intestine. Aft er ingestion, the probiotic encounters the acidic environment of the stomach; the 
gastric pH of a suckling piglet can reach values below three, and even lower values, less than 
two, have been recorded aft er weaning (Moughan et al., 1991; Snoeck et al., 2004). Aft er transit 
through the stomach, the acid stress is followed by exposure to bile in the duodenum. Apart 
for their digestive functions, both of these factors are also antimicrobial defense mechanisms 
of the GI-tract, causing stress to transiting microbes (Dunne et al., 2001; Upadrasta et al., 
2011). Exposure to an acidic environment, leading to a reduction in bacterial cytoplasmic 
pH, can decrease the activity of pH sensitive enzymes and damage the cell membrane and 
Literature review
11
macromolecules, such as DNA and proteins (van de Guchte et al., 2002; Cotter and Hill, 
2003). Th e antimicrobial eff ect of bile on the other hand is mainly due to the disruption on cell 
membrane integrity, but it may also infl uence macromolecular stability (Begley et al., 2005).
Th e acid and bile tolerance of lactobacilli isolated from various sources, including swine, 
have been extensively assessed (e.g. De Angelis et al. (2006); Yun et al. (2009); Guo et al. (2010); 
Zhang et al. (2013)), and while lactobacilli of intestinal origin usually show high tolerance of 
low pH and bile (Morelli, 2000), extensive strain-to-strain variability is evident. Th e in vitro 
experiments used in these tests have been based on exposing the strains to low pH or to bile for a 
limited time period, aft er which the bacterial population surviving the stress has been estimated, 
e.g. by plate count or turbidity measurements. Additionally, methods based on growth curve 
parameters have also been used (Morelli, 2000). Typically, the lowest pH values used in the 
experiments have been pH 2, and the bile concentration has ranged from 0.1% to 5%, but most 
oft en below 0.5%. Interestingly, diff erences according to the origin of the bile have been reported, 
as lactobacilli and bifi dobacteria were inhibited more by porcine bile than by bovine bile (Dunne 
et al., 2001). Nonetheless, the ability of these kinds of static experiments, using constant pH 
and / or bile concentration, to accurately predict the in vivo GI-tract survivability of the strains 
has been criticized (Morelli, 2000), as several factors related to the food matrix, ingestion and 
digestion have been observed to aff ect strain survival (Conway et al., 1987; Charteris et al., 
1998; Upadrasta et al., 2011). Th us, dynamic models possibly capable of simulating the GI-tract 
conditions more precisely have been developed (Marteau et al., 1997; Mainville et al., 2005; 
Ceuppens et al., 2012; Van den Abbeele et al., 2012). 
2.3.2.2 Adhesion
Th e intestinal motility causes a constant fl ow of the gut luminal contents, fl ushing the microbiota 
towards the distal intestine, and ultimately out of the host. In order to resist this fl ow and to 
maintain their population density at constant levels, bacteria need to either multiply rapidly, 
and / or to adhere to intestinal surfaces (Fuller, 1999; Morelli, 2000). Th us, adhesiveness is oft en 
considered to be an important characteristic for a candidate probiotic, as adhesive strains are 
generally assumed to have better abilities to at least temporarily colonize the intestine of the host, 
and to exist in an intimate contact with host cells, leading to more effi  cient functionality (Blum et 
al., 1999; Gueimonde and Salminen, 2006; Chassard et al., 2011). 
Several in vitro methods have been used for the assessment of the adherence of lactobacilli 
to intestinal structures (Blum et al., 1999; Morelli, 2000; Gueimonde and Salminen, 2006; Velez 
et al., 2007; Van Tassell and Miller, 2011). Th e main diff erence between these methods is the 
component of the intestinal mucosa being used as the substratum of adhesion. A schematic 
representation of the intestinal epithelium is shown in Figure 2. Th e intestinal epithelial cells, 
i.e. enterocytes, are covered by a mucus layer, a continuous viscous gel matrix consisting mainly 
of complex glycoproteins called mucins (Van Tassell and Miller, 2011). Th is layer protects 
the underlying cells, creating a physical barrier to bacteria-host interactions. Th us, mucus 
adhesion might be the fi rst step in bacterial colonization and interaction with the host. Th e 
ability of lactobacilli to adhere to porcine mucus has been assessed in several studies, and both 
commercially available mucins as well as mucus isolated from freshly collected intestines have 
been used (Li et al., 2008; Macias-Rodriguez et al., 2009; Iniguez-Palomares et al., 2011; Carasi 
et al., 2014).  
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Th e most widely applied method for the assessment of bacterial adhesion to intestinal 
epithelial cells is to use tissue culture cells as the target of adhesion (Lahtinen and Ouwehand, 
2009). Th e human derived carcinoma cell lines Caco-2 and HT29 (Rousset, 1986) have 
commonly been used in adhesion assays (Ouwehand and Salminen, 2003), including also those 
performed with lactobacilli originating from swine (Kim et al., 2007; Li et al., 2008; Zhang et 
al., 2013). However, the porcine derived cell lines IPEC-1 (Gonzalez-Vallina et al., 1996) and 
IPEC-J2 (Rhoads et al., 1994) have been reported to support the adhesion of swine pathogenic 
Escherichia coli strains better than the human derived cell line INT-407 (Koh et al., 2008). 
Th erefore, these swine specifi c cell lines might also be more appropriate for the adhesion assays 
performed with porcine lactobacilli.  While it is known that these tissue culture cell models do 
show morphological and functional diff erentiation and possess the characteristics of mature 
enterocytes (Chantret et al., 1988; Gonzalez-Vallina et al., 1996; Diesing et al., 2011), it is still 
somewhat unclear how well they represent intact intestinal epithelial cells. Freshly harvested 
intestinal tissue pieces and cells have consequently been postulated to represent a closer model of 
the intestinal epithelium (Morelli, 2000; Ouwehand et al., 2002). Both intestinal pieces as well as 
isolated enterocytes have been used to examine the adhesion of lactobacilli isolated from swine 
(Barrow et al., 1980; Mäyrä-Mäkinen et al., 1983; Lin et al., 2007; Guo et al., 2010). However, 
even this approach has its disadvantages, including practical diffi  culties such as availability 
and preservation of specimens. In addition, variability between animals from which the tissue 
samples are collected is likely to exist, and this would likely cause variations in bacterial adhesion 
as well. Furthermore, when using enterocytes collected from the intestine, the separation of cells 
from each other exposes the basolatelar sides of the cells to bacteria, which is not a relevant target 
of adhesion in the intact intestine (Ouwehand and Salminen, 2003). Th e use of whole intestinal 
tissue pieces preserves the intestinal wall architecture and may include also the covering mucus 
in addition to the enterocytes, providing perhaps a more natural model of the intestinal wall.
In addition to the intestinal cells and mucus, also ECM components, including type IV 
collagen, laminin and fi bronectin, have been used as the target of adhesion studies performed 
with lactobacilli (Styriak et al., 2003; Jakava-Viljanen and Palva, 2007).
Th e results of a large number of studies assessing the adhesion of lactobacilli to intestinal 
structures highlight their highly variable and strain specifi c adhesion pattern, swine lactobacilli 
being no exception (Barrow et al., 1980; Mäyrä-Mäkinen et al., 1983; Kim et al., 2007; Lin et 
al., 2007; Guo et al., 2010; Zhang et al., 2013). However, the lack of standardization in the assay 
protocols complicates comparison of the results obtained in the diff erent studies. Several factors 
have been observed to aff ect the results of adhesion studies; these include e.g. the buff er used, the 
pH, the presence of spent culture supernatant, the incubation time as well as the growth phase 
and concentration of the bacteria (Blum et al., 1999; Ouwehand and Salminen, 2003). Th us there 
is an obvious need for standardized methods to evaluate lactobacillar adhesion to intestinal 
structures. However, as at present it is impossible to say which method most accurately models 
the in vivo intestine, it is probably sensible to use more than one method when assessing the 
adhesion ability of lactobacilli and other bacteria. 
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Figure 2. Schematic representation of the components of the intestinal mucosa and 
submucosa. Components of the extracellular matrix are indicated with an asterisk. Th e 
Figure is reproduced from Velez et al. (2007) with permission granted by John Wiley and 
Sons.
2.3.2.3 Pathogen inhibi? on
Th e ability to inhibit pathogenic microbes is considered to be highly desirable property 
for probiotics, as this characteristic is anticipated to confer better gut health for the host 
(Vandenbergh, 1993; Servin and Coconnier, 2003; De Vuyst and Leroy, 2007). Generally, the in 
vitro studies have assessed the ability of probiotic microbes to inhibit two diff erent aspects of 
pathogen function: their adhesion to intestinal structures, and their growth (Fernandez et al., 
2003; Servin and Coconnier, 2003).
As adhesion to the intestinal epithelium is the fi rst step in the pathogenesis of many GI-tract 
infections (Gyles and Prescott, 2010), inhibition of pathogen adhesion by probiotic microbes 
could be assumed to reduce the occurrence of these diseases (Holzapfel et al., 1998). While 
the mechanisms by which probiotics, including lactobacilli, inhibit the adhesion of pathogens 
have been poorly characterized, several possible modes of action have been proposed, e.g. 
competition for adhesion sites and steric hindrance, as well as stimulation of mucin production 
by intestinal cells (Servin and Coconnier, 2003; Servin, 2004). Th e in vitro methods applied to 
assess inhibition of pathogen adhesion by probiotics have used the same substrata for adhesion 
as the regular adhesion assays, i.e. swine intestinal mucus (Jin et al., 2000; Collado et al., 2007), 
tissue culture cells (Bogovic Matijasic et al., 2006; Zhang et al., 2013) including IPEC-1 (Roselli 
et al., 2007), isolated enterocytes (Spencer and Chesson, 1994), as well as resected ex vivo jejunal 
tissue (Bogovic Matijasic et al., 2006). Th ree experimental set-ups have commonly been used: i) 
competition (simultaneous addition of the probiotic and the pathogen), ii) exclusion (addition 
of the probiotic prior to the pathogen) and iii) displacement (addition of the pathogen prior to 
the probiotic). Similarly to adhesiveness, inhibition of pathogen adhesion by lactobacilli displays 
extensive variability; this is a species and / or strain dependent property, being furthermore 
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aff ected by the assay methodology (Spencer and Chesson, 1994; Collado et al., 2007; Roselli et 
al., 2007; Zhang et al., 2013). 
Th e ability of lactobacilli to inhibit the growth of other microbes is well-established, and 
this property has for a long time been utilized in food preservation. Inhibition of pathogen 
growth would be highly desirable also for lactobacilli when they are used as probiotics (Saarela 
et al., 2000). Th e microbial growth inhibition caused by lactobacilli is primarily due to the 
production of organic acids, mainly lactic acid, and concomitant lowering of the pH (Nes et 
al., 2012). Th e inhibitory action of lactic acid is likely caused by the undissociated form of 
this acid, which is favored at low pH, and which can cross the cell membrane entering the cell 
cytoplasm. Subsequently, as the pH inside the cell is higher than outside the cell, the molecule 
will dissociate, disrupting intracellular pH homeostasis and aff ecting metabolic processes of the 
cell (Brul and Coote, 1999; Nes et al., 2012). Lactic acid has also been shown to permeabilize 
the outer membrane of Gram-negative bacteria, and sensitizing them to other antimicrobial 
compounds, like lysozyme (Alakomi et al., 2000). In addition to weak organic acids (such as lactic 
acid), also other metabolic products produced by lactobacilli, such as free fatty acids, ammonia, 
ethanol, diacetyl and hydrogen peroxide, may contribute to the growth inhibition, although to 
a lesser extent (Vandenbergh, 1993; Nes and Johnsborg, 2004). Furthermore, certain strains of 
lactobacilli produce specifi c antimicrobial compounds, including bacteriocins and reuterin (Nes 
et al., 2012). While reuterin has a broad antimicrobial spectrum, acting against Gram-positive 
and Gram-negative bacteria, fungi, protozoa and even viruses (Nes et al., 2012),  bacteriocins are 
primarily targeted against closely related bacteria, although a broader target specifi city including 
also pathogenic bacteria has been recognized for some members of this group of antimicrobials 
(Jack et al., 1995; Servin, 2004; Nes et al., 2012).     
Th e in vitro screening of antimicrobial properties has usually been based on assessing the 
growth inhibition of selected bacteria, or so called “indicator organisms”, in solid or in liquid 
medium (Cabo et al., 1999; Papagianni et al., 2006). Th e agar diff usion assay, resembling the 
disc diff usion assay for antibiotic susceptibility, has been a very commonly applied method for 
investigating the antimicrobial properties of lactobacilli (De Mitchell and Kenworthy, 1976; du 
Toit et al., 2000; Klose et al., 2010a; Klose et al., 2010b). In this method, the growth inhibition of 
the indicator organism is quantifi ed by measuring the growth-free zone around the lactobacilli 
spotted on the agar, or in wells containing the spent culture fi ltrate (SCF) (Davidson and Parish, 
1989). Several factors, including the diff usion rate of the antimicrobial compounds and the 
composition of the agar are known to aff ect the results of agar based methods (Davidson and 
Parish, 1989; Piddock, 1990). In addition, measurement of the inhibition zones can be diffi  cult 
and subjective. Unexpectedly, when the same Lactobacillus strains were tested with both the agar 
spot and the well diff usion methods, the results obtained did not correlate well with each other 
(Hernández et al., 2005). Consequently, liquid-medium methods, which eliminate the diff usion 
related problems, have been proposed to be more accurate and reliable (Cabo et al., 1999). In 
these assays, the indicator organism is grown in liquid media supplemented with lactobacillar 
SCF (Kim et al., 2007; Bernardeau et al., 2009; Guo et al., 2010), or alternatively co-cultured in 
the same test tube with the Lactobacillus strain (Drago et al., 1997; Annuk et al., 2003; Fernandez 
et al., 2003). Growth inhibition of the indicator organism can be quantifi ed in several ways, 
including plate count (Drago et al., 1997; Moslehi-Jenabian et al., 2011) and bioluminescence 
(Vesterlund et al., 2004), but measurement of optical density is a simple and widely applied 
method (Davidson and Parish, 1989; Turcotte et al., 2004). Turbidometry has oft en been used 
as an end-point method, when the quantifi cation of the growth inhibition is performed aft er a 
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lengthy incubation period (e.g. overnight), at the stationary growth phase of the indicator (Daba 
et al., 1991; Parente et al., 1995; Cabo et al., 1999; Lee et al., 2003). However, kinetic recording of 
the indicator growth over the whole incubation period gathers more information on the eff ects 
caused by the inhibitory compounds (Davidson and Parish, 1989; Skyttä and Mattila-Sandholm, 
1991), and several growth curve parameters can be used to quantify the growth inhibition of the 
indicator organism (Adams and Hall, 1988; Mattila and Sandholm, 1989; Skyttä and Mattila-
Sandholm, 1991). While the methods involving liquid media have some advantages over agar 
based methods, their results may also be aff ected by several factors, such as the inoculum size of 
the indicator and incubation parameters (Davidson and Parish, 1989; Piddock, 1990).
Th e ability of porcine lactobacilli to inhibit the growth of various swine pathogens, including 
diff erent strains of E. coli, Salmonella, Listeria, Staphylococcus, Brachyspira and Clostridium 
have been observed in several studies (du Toit et al., 2000; Chang et al., 2001; De Angelis et al., 
2006; Kim et al., 2007; Lin et al., 2007; Guo et al., 2010; Klose et al., 2010a; Klose et al., 2010b). 
However, as in the case of adhesion assays, the results from diff erent studies are diffi  cult to 
compare due to methodological diff erences. Furthermore, as pathogen inhibition in the complex 
gut environment is likely to be aff ected by the whole intestinal microbiota, fermentation models 
simulating the GI-tract conditions, including possible changes in the microbiota composition 
aft er the addition of lactobacilli, have been developed (Chassard et al., 2011).
2.3.2.4 Immunological e? ects 
Th e co-evolution of the commensal microbiota with its host has led to a fi nely tuned crosstalk 
between the partners in this symbiotic relationship (Artis, 2008; Neish, 2009). Th is dynamic 
interaction occurs for the most part at the epithelial surfaces, and it is orchestrated by the immune 
system. Commensal microbiota, including lactobacilli, is known to regulate the immune system 
functions of the host, with both immunostimulatory as well as anti-infl ammatory eff ects being 
observed (Corthesy et al., 2007; Wells, 2011b; van Baarlen et al., 2013). Additionally, lactobacilli 
and other commensals have an important role in the establishment of immune tolerance in the 
intestine (Round et al., 2010; Finamore et al., 2012). Benefi cial immunomodulatory properties 
would be a highly desirable characteristic for lactobacilli aimed to be used as probiotics, as these 
could lead to e.g. increased disease resistance via enhanced immune response against pathogens 
and / or alleviation of allergic or infl ammatory symptoms (Saarela et al., 2000; Meijerink and 
Wells, 2010; Chassard et al., 2011). 
Th e immunomodulatory actions of lactobacilli can be triggered by several mechanisms, 
including infl uencing the maturation and functions of dendritic cells (DCs) (Borchers et al., 2009; 
Wells, 2011b). Th ese sentinel cells have a central role in the activation of immune responses, as 
they are the most potent antigen presenting cells, and have the ability to activate naïve T-cells 
(Kelsall et al., 2002; Mildner and Jung, 2014). Additionally, DCs direct the activation of T 
cells in such a way to result in the triggering of an appropriate type of immune response (e.g. 
Th 1 / Th 2 / Th 17 / Treg) and this guidance occurs mainly through the secretion of cytokines, as 
well as via costimulatory signals provided by cell surface molecules (Mildner and Jung, 2014). 
In vitro co-culture assays have been extensively used in assessing the eff ects of lactobacilli on 
DC maturation and cytokine production. Since intestinal DCs are diffi  cult to obtain, these 
experiments have usually been conducted with DCs derived from peripheral blood monocytes 
(MoDCs), or from bone marrow (BMDCs) (Borchers et al., 2009). It appears that there are at 
least some diff erences in the responses of DCs originating from the diff erent compartments of 
the body (Hart et al., 2004; O’Mahony et al., 2006; Fink and Frokiaer, 2008), so it remains to be 
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determined how well the results obtained with peripheral DCs can be extrapolated to those of 
intestinal origin. Considering the species origin of the cells, human and murine DCs have by 
far been the most extensively applied, with swine-derived DCs seldom being used. Th e priming 
eff ect of lactobacilli on DCs can be estimated by measuring the production of selected cytokines 
(e.g. interleukin (IL) 10, IL-12 or tumor necrosis factor (TNF) α) or the expression of certain 
surface markers (e.g. cluster of diff erentiation (CD) molecules like CD40, CD80 and CD86) 
(Mohamadzadeh et al., 2005; Smits et al., 2005; Konstantinov et al., 2008b; Verbeek et al., 2010; 
Gad et al., 2011). In addition, co-incubation of the lactobacilli-primed DCs with Th  cells has 
been used to reveal the resulting modulations of T cell diff erentiation (Mohamadzadeh et al., 
2005; Smits et al., 2005; Konstantinov et al., 2008b). 
In addition to modifying the functions of immune cells like DCs, lactobacilli can interact 
with intestinal epithelial cells (IECs) (Borchers et al., 2009; van Baarlen et al., 2013). While the 
intestinal epithelium is a crucial barrier between the gut lumen and underlying host tissues, it 
is also an active player in the regulation of intestinal homeostasis and immunity (Artis, 2008). 
Lactobacilli and other commensals have been shown to infl uence the functions of the IEC, such 
as their production of signaling molecules e.g. cytokines (Artis, 2008; Borchers et al., 2009). Th e 
in vitro experiments assessing the possible alterations in IEC cytokine expression induced by 
lactobacilli have mainly used the same tissue culture cells as the adhesion studies, namely Caco-2 
cells (Morita et al., 2002; Roselli et al., 2006) and HT- 29 cells (McCracken et al., 2002), as well 
as two cell lines originating from swine, IPEC-J2 (Liu et al., 2010), and PIE (Hosoya et al., 2011). 
Furthermore, as it is evident that in the intestinal environment a close interaction occurs also 
between IECs and lamina propria DCs, in vitro experiments combining these two cell types in 
a transwell culture system have also been conducted (Zeuthen et al., 2008; Villena et al., 2014). 
Similarly to the other potentially probiotic characteristics of lactobacilli, considerable 
species- and strain-specifi c diff erences have been observed in the in vitro immunomodulative 
properties of lactobacilli (reviewed e.g. by Borchers et al. (2009); Meijerink and Wells (2010); 
Wells (2011b)). Priming of DCs towards the production of regulatory T cells (Smits et al., 2005), 
Th 2 cells (Konstantinov et al., 2008b) as well as Th 1 cells (Mohamadzadeh et al., 2005) has been 
described, and the bacterial dose used aff ects these responses (Smits et al., 2005; Konstantinov et 
al., 2008b; Gad et al., 2011). While epithelial cell lines have been unresponsive to some strains of 
lactobacilli (O’Hara et al., 2006; Candela et al., 2008), stimulation of these cells by lactobacilli can 
result to production of pro- and / or anti-infl ammatory cytokines (Roselli et al., 2006; Zeuthen 
et al., 2008). Moreover, lactobacilli have been observed to modulate the infl ammatory responses 
of DCs and IECs induced by pathogenic bacteria (Vizoso Pinto et al., 2009; Villena et al., 2014), 
indicating possible advantageous outcomes for the host.  
2.3.2.5 An? bio? c resistance
Resistance to antibiotics is an ancient protection mechanism of bacteria (D’Costa et al., 2011), 
which nowadays is widely disseminated in bacterial communities due to the modern over-use of 
antibiotics. In addition to pathogenic bacteria, also commensals and environmental bacteria as 
well as those used in the food industry are known to harbor antibiotic resistance determinants 
(Riesenfeld et al., 2004; Sommer et al., 2010; Devirgiliis et al., 2013), and the horizontal transfer 
of resistance genes from these reservoirs to pathogens poses a major threat to both human and 
animal health. Consequently, evaluating the antibiotic resistance patterns and mechanisms 
exhibited by potentially probiotic bacteria is an integral part of the safety assessment (Saarela 
et al., 2000; von Wright, 2005; Clementi and Aquilanti, 2011). According to the FEEDAP Panel 
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(Panel on Additives and Products or Substances used in Animal Feed), strains carrying an 
acquired antibiotic resistance resulting from genes located in transmissible elements are not 
acceptable for use as feed additives (EFSA, 2012). 
A broad variety of in vitro techniques, including both agar and broth-based methods, have 
been used to assess the antibiotic resistance of lactobacilli (Salminen et al., 2006; Klare et al., 2007; 
Mayrhofer et al., 2008; Rabia and Shah, 2011; Mayrhofer et al., 2014), limiting the comparability 
and interpretation of the results. However, the technical guidance of the FEEDAP panel includes 
instructions for methods suitable for determination of minimum inhibitory concentration 
(MIC), as well as the microbiological breakpoints for selected antibiotics categorizing potential 
probiotics, including lactobacilli, as resistant (EFSA, 2012). 
Although lactobacilli are naturally resistant to a wide range of antibiotics, this resistance is 
generally not due to transmissible elements but instead it is of the intrinsic type, not considered to 
be a safety concern (Saarela et al., 2000; Rabia and Shah, 2011). For instance, intrinsic resistance 
towards vancomycin is common among species of lactobacilli (Saarela et al., 2000; Gueimonde et 
al., 2013). However, also resistance genes located in mobile genetic elements potentially able to be 
transferred to other microbes have been found in lactobacilli (Rabia and Shah, 2011; Devirgiliis 
et al., 2013; Gueimonde et al., 2013), and transmission of some of the elements to other bacteria 
has been shown to occur (Feld et al., 2008; Devirgiliis et al., 2009).
In addition to the safety concerns regarding lactobacillar antibiotic resistance, this property 
can also be utilized when isolating lactobacilli from complex communities, e.g. the GI-tract. 
For example, in an in vivo feeding trial, the re-isolation of the supplemented strain among the 
commensal gut microbiota can be highly challenging. Th e usage of strains harboring resistance 
to particular antibiotics would enable antibiotic selection in the bacterial culture, increasing the 
probability of detecting the right strain(s) among the indigenous lactobacilli (Casey et al., 2007; 
De Angelis et al., 2007; Walsh et al., 2008).
2.3.3 In vivo studies
Aft er the preliminary selection of the candidate strain(s) by in vitro methods, the functionality 
of the putative probiotic strain has to be validated in in vivo trials. Th ese should be preferably 
performed in the intended target host species, although mechanistic studies focusing on 
molecular level functions of the strain are oft en performed in rodent models (Mileti et al., 
2009; Pagnini et al., 2010; Castillo et al., 2013). Th e authorization process of microbial feed 
additives, based on Regulation (EC) No. 1831/2003, requires that the effi  cacy of the supplement 
is established, and usually three target animal studies showing statistically signifi cant benefi ts 
on relevant parameters are required. Th e FEEDAP panel has issued technical guidance on the 
performance of effi  cacy trials on target animals (EFSA, 2011).  
To be able to deduce whether the strain tested actually “works”, i.e. confers desirable 
outcomes to the host, specifi c measurable endpoints have to be defi ned. In production animals, 
and to some extent also in companion animals as well as in humans, the use of probiotic microbes 
diff er from the use of most pharmaceuticals, as the main aim is to maintain and improve health 
rather than to cure a clinical disease. However, animal health and well-being is a complex concept 
which is not always easily measured (Clark et al., 1997; Meieregger et al., 2011). In addition, in 
the case of production animals, productivity is of major importance, and while this aspect does 
not necessarily strictly correlate with animal well-being (Frazer, 1993; Clark et al., 1997), it needs 
to be taken into account in probiotic feeding trials. Indeed, the measures most commonly used 
in feeding trials performed in production animals relate to the productivity of the animal, but 
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also other endpoints, like alterations in the composition of the intestinal microbiota and in the 
immune function of the host are commonly used (Bosi and Trevisi, 2010; Kenny et al., 2011; 
Meieregger et al., 2011).
Numerous feeding trials using potentially probiotic Lactobacillus strains have been 
performed in swine, and as can be seen from Table 3, the results have been highly variable. 
Interpretation of these results is hampered by the fact that several aspects in the study design, 
including those related to the supplemented microbe or to the host animal, can aff ect the 
outcomes of in vivo feeding trials (Bernardeau et al., 2006; Lim and Tan, 2009; Rijkers et al., 
2010). 
While the bacterial species and strain used are obviously important variables in probiotic 
feeding trials, the bacterial dose administered to the animals can also infl uence the results 
obtained (Li et al., 2012; Suo et al., 2012; Wen et al., 2012; Zhu et al., 2014). However, probiotic 
functionality in terms of dose-dependence has not been extensively investigated in feeding trials 
performed in swine, and the dosages of bacteria used have typically been in the range from 
108 to 1010 CFU, with these being administered daily or at diff erent time intervals, e.g. once 
a week  (Table 3). In addition, although using only single strain supplementation has been a 
common approach, multi-strain or multi-species preparations have also been investigated in 
several studies (Table 3). Th e combination of probiotic strains possessing characteristics that 
complement each other might help to overcome the problems related to species– and strain–
specifi city of the benefi cial properties (Collado and Salminen, 2009).  Moreover, as host related 
factors also contribute to the host–microbe interaction, the performance of a probiotic microbe 
is likely to vary between diff erent host individuals. Consequently, multistrain /–species products 
might function more eff ectively and more consistently than a monostrain product. Since most of 
the studies that have been performed using combinations of diff erent strains were not specifi cally 
designed to compare the eff ects of a multistrain supplementation to those of the same strains 
applied singly, it is diffi  cult to evaluate the possible diff erences in benefi cial outcomes between 
these approaches. However, there are some indications that multistrain products may perform 
better that their monostrain counterparts (Nousiainen et al., 2004; Timmerman et al., 2004; 
Collado and Salminen, 2009; Chapman et al., 2011).
In addition to factors related to the strain(s) used in the supplementation, there are also 
several practical issues that can infl uence the results of an in vivo feeding trial. Th e production 
environment and management practices are known to impact on the gut microbiota 
composition of swine (Davis, 2012), thus these factors probably also aff ect the interplay between 
the supplemented strain and the commensal microbiota. In addition, the hygiene level of the 
production facility can play an important role, since exposure to pathogenic bacteria and the 
subsequent infection incidence can be very variable in diff erent environments. Consequently, the 
most pronounced eff ects of probiotic supplementation might be observed in facilities with lower 
level of hygiene and / or in circumstances infl icting stress on the animals (Fuller, 1989; Th omke 
and Elwinger, 1998; Kritas and Morrison, 2007), and the same has been proposed also for in-feed 
antimicrobials (Fuller, 1989; Dritz et al., 2002; Kenny et al., 2011). In addition, the time frame 
of probiotic application, including the age of the animals used and the length of the trial, has 
diff ered in the various experiments performed, and is likely to have an impact on the observed 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.3.3.1 E? ects on produc? vity parameters
A high level of biological functioning can be considered as one aspect of animal well-being 
(Frazer, 1993), thus the assessment of certain performance parameters to detect changes in 
productivity is frequently used to estimate the possible eff ects of bacterial supplementation. 
Productivity measures are also extremely important for the producer, as higher productivity 
yields better fi nancial returns. Th e average daily weight gain (ADWG) is the most commonly 
utilized measurement of productivity, used mainly in fattening farm animals (Meieregger et al., 
2011). Other parameters that are oft en used are the daily feed intake (DFI), as well as the feed 
conversion ratio (FCR), which quantifi es the relation between DFI and ADWG, measuring the 
effi  ciency in converting food mass into body mass. Depending on the production category of 
the animal, the usual range for FCR is 1 : 1.5-4 for swine and poultry, and 1 : 6-7 for cattle 
(Meieregger et al., 2011), with high-performing animals showing lower ratios indicating that less 
feed is needed to produce the same amount of meat. In production animals not in the fattening 
category, other parameters, such as those related to reproduction (e.g. the litter size and weight, 
sow weight loss aft er birth) can be used to assess the eff ects of probiotic supplementation 
(Böhmer et al., 2006). 
Th e mechanisms behind the improved performance caused by bacterial supplementation 
are not fully understood, but some of the putative actions of probiotics possibly contributing to 
enhanced host growth are summarized in Figure 3. Lactobacilli and other benefi cial microbes 
have been proposed to contribute to the nutrition of the host e.g. by synthesizing vitamins and 
breaking down nutritional components that the host is unable to metabolize, possibly improving 
nutrient bioavailability (Kopp-Hoolihan, 2001; Turpin et al., 2010; Kenny et al., 2011; Ezema, 
2013). However, as the cell numbers of supplemented bacteria are low compared to that of the 
commensal microbiota, the relevance of their possible contribution to nutrition may be minor. 
Modifi cation of the host gut physiology, such as increasing the production of growth factors, 
might also be a mechanism through which lactobacilli can enhance host growth (Turpin et al., 
2010). In addition, stabilization of the gut microbiota resulting in a reduced pathogen load has 
been postulated to induce increased growth (Kenny et al., 2011).
In swine, highly variable results have been obtained on studies assessing the ability of various 
Lactobacillus supplementations to benefi cially aff ect the productivity, with some studies showing 
improved performance while others have not detected any benefi ts (Table 3). With regard to 
growth promotion, the percentage improvements in the weight gain of starter piglets has oft en 
ranged from around 2 to 10% (Fuller, 1989; Meieregger et al., 2011), and while several studies 
have failed to achieve statistical signifi cance, a general tendency towards an elevated growth rate 
in piglets supplemented with probiotics has been reported in numerous studies, as reviewed by 
Simon et al. (2001). Th e FEEDAP panel has issued scientifi c opinions regarding the ability of 
certain Lactobacillus preparations to enhance swine growth performance and some products 
have been concluded to increase the growth of piglets (EFSA, 2008, 2013). Studies performed in 
growing-fi nishing pigs are rarer, and the responses in growth enhancement have usually been of 
lower magnitude than those observed in young piglets (Nousiainen et al., 2004).  
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Figure 3. Probiotics can improve host growth by increasing biodisponibility of 
macronutrients (1), degradation of antinutrient factors (2), enhancement of mineral 
absorption (3), and production of growth factors (4). Th e other squares indicate the 
mechanism involved in host growth. Th e Figure is reprinted from Turpin et al. (2010) with 
permission granted by Elsevier.
2.3.3.2 E? ects on gut microbiota
Th e GI-tract microbiota is known to be a signifi cant factor aff ecting the health and well-being of 
the host, and positive eff ects on this complex community are believed to be one of the mechanisms 
behind probiotic action (Simon et al., 2001; Gueimonde and Salminen, 2006; Bosi and Trevisi, 
2010). Consequently, the possible alterations of the gut microbiota attributable to lactobacilli 
consumption have been commonly monitored in porcine feeding trials. While it is not so 
straightforward to determine what kind of changes in the GI-tract microbiota can be considered 
as favorable for the host (Simon et al., 2001), an increase in the numbers of “benefi cial” microbes, 
such as lactic acid bacteria and bifi dobacteria is oft en interpreted as a positive outcome aft er 
lactobacilli supplementation (Simon et al., 2001; Nousiainen et al., 2004; Meieregger et al., 2011). 
Additionally, a reduction in the numbers of potentially pathogenic microbes, like enterobacteria 
including E. coli, has been proposed to be an advantageous change (Simon et al., 2001; Nousiainen 
et al., 2004; Meieregger et al., 2011). Both of these responses have been described in swine aft er 
supplementation with lactobacilli (Table 3). However, since a large part of these studies have 
been based on bacterial culture methods, the results are biased towards cultivable species, and 
provide only a partial picture of the changes occurring in the intestinal microbiota. Th e use of 
culture-independent molecular techniques allows a more complete description of the possible 
eff ects bacterial supplementation might have on the intestinal microbiota composition. 
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In addition to general changes in the composition of the intestinal microbiota, also the fate 
of the administered strain is of interest. Survivability of the feeding strain through the GI-tract, 
and possibly even colonization of the host intestine have been stated as necessary characteristics 
for a probiotic microbe (Vaughan et al., 1999; Marco et al., 2006). While the GI-transit 
survivability has been demonstrated for certain strains of lactobacilli in feeding trials performed 
in swine (Table 3), this factor has not been investigated in the majority of the trials. Moreover, 
colonization of the intestine by the supplemented strain has been evaluated even more rarely in 
swine and only for short periods of time (Pedersen and Tannock, 1989; Gardiner et al., 2004; De 
Angelis et al., 2007). While permanent colonization of the host intestine by an allochthonous (i.e. 
exogenous) strain is easily achieved in gnotobiotic animals (Servin and Coconnier, 2003; Smith 
et al., 2007), the colonization resistance exerted by the commensal microbiota seems to be strong 
as the exogenous strain administered usually disappears from the intestine aft er discontinuation 
of consumption (Bezkorovainy, 2001; Ouwehand and Salminen, 2003; Isolauri et al., 2004). 
Even the adhesive L. rhamnosus strain GG does not seem to permanently colonize the human 
GI-tract (Bezkorovainy, 2001), nonetheless its persistence has been reported in colonic mucosa 
even although it was not recovered from fecal samples (Alander et al., 1999). In addition, the age 
of the host at the time of probiotic administration may be an important factor, as L. rhamnosus 
strain GG was found to persist for as long as 24 months in babies when administered to their 
mothers during late pregnancy (Schultz et al., 2004). Th is implies that application of probiotics in 
the neonatal period, when the commensal microbiota is not yet fully developed, may be optimal 
for intestinal colonization with the desired bacterial strain. Interestingly, a strain of L. acidophilus 
(LAB20) isolated from a dog was found to persist in the intestine of a dog at least for six weeks 
(Tang and Saris, 2013), thus there probably exist diff erences in colonization ability attributable to 
the bacterial strain as well as the host species.
2.3.3.3 E? ects on host immune func? on
Th e in vivo immune modulating actions of lactobacilli have been demonstrated in several trials, 
performed for the most part in mouse models as well as in humans, and have included shift s in the 
balance of diff erent T cell types, stimulation of regulatory immune mechanisms (e.g. generation 
of Treg cells), alterations in cytokine expression patterns, increases in the production of antibodies 
and in the activity of certain immunological cells (e.g. natural killer cells, macrophages and other 
phagocytes) as well as modifi cations in the functions of the intestinal barrier (Borchers et al., 
2009; Meijerink and Wells, 2010; Wells, 2011b; van Baarlen et al., 2013). In lactobacilli feeding 
trials performed in swine, the most commonly measured immunological parameter has been 
the expression levels of cytokine genes in the intestine or other tissues, but also immune cell 
populations in the gut mucosa or peripheral blood as well as immunoglobulin concentrations 
have been investigated in some of the trials (Table 3). 
While lactobacilli and other probiotic microbes obviously do have the capability to modify 
host immune responses, the question still remain open; are the observed eff ects actually benefi cial 
for the host? When taking into account the complexity of the immune system, interpretation of 
the data obtained from the in vivo studies is highly problematic and mere immunostimulation 
or some other alteration does not necessarily represent a positive health eff ect. A more detailed 
understanding of the immune system mechanisms are needed to unravel the consequences of 
the changes that probiotic microbes induce in the host immune function.  
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2.3.3.4 E? ects on disease occurrence
As a reduced occurrence of diseases, especially of diarrheal diseases, is one of the health claims 
for benefi cial microbes, this outcome has been frequently explored in probiotic feeding trials, 
both in humans and animals (Fuller, 1989; Simon et al., 2001). Reductions in disease incidence 
or prevalence would lead to improved animal welfare and oft en also to increased productivity. GI 
infections are very common in the pig production, causing signifi cant fi nancial losses. Diarrheal 
diseases especially in the neonatal and post-weaning period are a major problem, which 
traditionally has been combated with the use of therapeutic and in-feed antimicrobials (Bomba 
et al., 2012). While there are several diff erent bacteria and viruses that can cause neonatal and 
post-weaning diarrhea in piglets, diff erent enterotoxigenic E. coli (ETEC) strains possessing F4, 
F5, F6, F7 and F18 fi mbriae are those most commonly detected (Melkebeek et al., 2013).
Two diff erent study designs can be applied to assess the ability of a bacterial supplement 
to reduce disease occurrence in vivo. In fi eld trials, the effi  cacy of the potential probiotic is 
estimated in regular production farms, i.e. under “real life conditions”. However, for practical 
reasons, these kinds of studies are very challenging to perform, and a large number of animals 
is needed to achieve signifi cant and biologically relevant results. Th erefore, studies in which the 
animals are deliberately challenged with infectious organisms to cause a disease are oft en used 
to estimate the disease preventive ability of lactobacilli and other probiotic microbes. In the 
challenge studies that have been performed in swine, diff erent E. coli strains have been the most 
oft en used pathogens, but strains of Salmonella have also been used (Table 4). In several studies, 
the supplemented probiotic strain has been able to alleviate the symptoms and reduce the fecal 
excretion of the pathogen, as well as to modify the pathogen induced immune responses of the 
host animal (Table 4). Th e mechanisms behind the protective eff ect of probiotic bacteria against 
pathogens remain unresolved, although several have been postulated, including competition for 
adhesion sites or nutrients, production of antibacterial substances that inhibit pathogen growth 
and survival, prevention of pathogen actions by agglutinating with the pathogen and inhibition 
of the production of pathogen toxins (Fuller, 1989; Nousiainen et al., 2004; Turpin et al., 2010). 
In the future, more detailed studies will help to reveal the interactions between the supplemented 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.3.4 Correla? on of in vitro and in vivo studies
As the purpose of the in vitro tests is to predict which of the candidate probiotic strains would 
perform best in the target animal species, the correlation of the results obtained in these screening 
tests to the in vivo fi ndings is very important. However, it is a very diffi  cult task to systematically 
and extensively evaluate this matter. Additionally, studies which have estimated the correlation 
of in vitro and in vivo results are, for the most part, based on experiments performed in humans 
or mouse, and only few studies executed in swine have evaluated this topic.
Th e tests for tolerance of low pH and bile are intended to demonstrate which strains will be 
able to survive the transit through the host GI-tract. Indeed, several studies performed both in 
humans (Pochart et al., 1992; Jacobsen et al., 1999; Dunne et al., 2001) and swine (Gardiner et 
al., 2004; De Angelis et al., 2007) have shown that strains exhibiting in vitro tolerance to low pH 
and bile are able to survive intestinal passage. Additionally, the in vitro survival results obtained 
in a dynamic model of the human GI-tract correlated well with in vivo data (Marteau et al., 
1997). However, appropriate in vivo comparison of strains with diff ering performances in the in 
vitro stress tolerance tests has not usually been performed in these studies. Furthermore, those 
strains that are known to survive human GI-tract transit in vivo, e.g. L. rhamnosus GG (Goldin 
et al., 1992; Alander et al., 1999), have sometimes performed poorly in in vitro tests (Mattila-
Sandholm et al., 1999; Morelli, 2000; Mainville et al., 2005). Th us, at least some of the in vitro 
test conditions used in the stress tolerance assays may well be too harsh as compared to the in 
vivo situation. Additionally, as the food matrix protects the supplemented bacteria during gastric 
passage (Conway et al., 1987; Charteris et al., 1998), strains with poor in vitro acid tolerance may 
well be able to tolerate the in vivo GI-tract environment.
Good adhesiveness to the intestinal wall structures has been considered to be an important 
property for probiotic microbes mainly for three reasons: adherent strains might 1) more easily 
colonize the host intestine, 2) exclude pathogens by competing for adhesion receptors, 3) induce 
immune modulatory actions via their close contact with host cells (Ouwehand and Salminen, 
2003; Lahtinen and Ouwehand, 2009). With regard to colonization, as already discussed in 
section 2.2.3.2, it seems however that even adhesive strains cannot permanently colonize the 
host intestine. Based on studies performed in humans (Jacobsen et al., 1999; Morelli, 2000) and 
in various animals (i.e. chickens (Fuller, 1978), mouse (Zarate et al., 2002) and fi sh (Sugimura et 
al., 2011)) it seems that in vitro adhesion ability of a bacterial strain may predict in vivo adhesion 
and / or persistence in the host intestine. However, the adhesion ability by itself is apparently not 
suffi  cient to ensure a prolonged persistence of the strain in the gut environment. Th is is illustrated 
by results obtained in mouse showing that also non-adherent strains can temporarily colonize 
the host intestine (Hautefort et al., 2000). On the other hand, studies performed in humans 
(Morelli, 2000) and swine (Nousiainen et al., 2004) have revealed that adhesive strains do not 
necessarily succeed in colonization. Consequently, the correlation between in vitro adhesiveness 
and transient gut colonization is not clear. Interestingly, when comparing isogenic variants of L. 
crispatus diff ering in their in vitro aggregation and adhesion abilities, the low-adhesive mutant 
was not detected in the feces or biopsies of human volunteers, while the more adhesive parent 
strain was found (Cesena et al., 2001), and the same was observed also in experiments conducted 
in mice (Voltan et al., 2007). Future studies with a similar approach of using isogenic strains 
diff ering only in their adhesion ability may help clarify the correlation of in vitro adhesiveness to 
in vivo colonization capacity. 
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While in vivo challenge studies performed in swine have shown that lactobacilli and other 
probiotics are able to exclude pathogens, and there is some evidence that lactobacilli could use the 
same attachment sites as pathogens (Lebeer et al., 2008), the importance of probiotic adhesion 
in pathogen exclusion is still rather unclear. A non-adhering mutant of the strain L. plantarum 
299v was, in contrast to the wild type, unable to inhibit the adhesion of an E. coli strain to HT-29 
cells, which indicates that adhesion ability may be important for pathogen exclusion (Mack 
et al., 2003). However, it appears that even if a strain has a high adherence ability, it may not 
necessarily inhibit pathogen adhesion to cultured intestinal epithelial cells (Bibiloni et al., 1999), 
and also other mechanisms have been proposed to be involved in pathogen exclusion, including 
coaggregation with the pathogen (Lebeer et al., 2008).
In addition to the colonization ability and / or pathogen exclusion properties, adhesiveness 
is also considered important for the immunomodulatory actions of a probiotic strain. Obviously, 
stimulation of the immune system requires an intimate contact between the bacteria and host 
cells, and this typically occurs via specifi c receptors, e.g. pattern recognition receptors (PRRs) 
binding to certain structures on the microbial surface, inducing signaling pathways that trigger 
immunological responses (Murphy, 2012). As reviewed by Lebeer et al. (2010), these kinds of 
interactions also take place between probiotic bacteria and the host. However, this does not reveal 
whether adhesion to enterocytes is necessary to obtain the immunological actions of probiotics. 
While studies performed in humans have given some indications that highly adhesive strains 
have a greater eff ect on the immune system than their less adhesive counterparts (Ouwehand 
and Salminen, 2003), it cannot be concluded for certain that these immunological diff erences 
are specifi cally due to the diff ering adherence properties of the strains. Th us far, few studies 
have been performed with isogenic strains; in one such study the aggregating and adhesive 
strain L. crispatus M247 induced changes at the mRNA levels of Toll-like receptor (TLR) 2 and 
TLR 4 in the colonic mucosa of mice, while the less adhesive mutant strain had no eff ect on these 
parameters (Voltan et al., 2007). Th is observation indicates that an aggregative and / or adhesive 
phenotype is important in modulating murine enterocyte responsiveness, but for the most part, 
the role of adhesiveness in probiotic immunomodulation still remains to be elucidated.  
Th e comparison of in vitro and in vivo immunomodulatory properties of probiotic bacteria 
is complicated by the extreme complexity of the host immune system, as only a few parts of this 
vast network can be examined in laboratory experiments. However, at least some correlations 
seem to exist between certain in vitro measures and in vivo immune functionality. In chickens, 
provision of lactobacilli strains which enhanced the proliferation of suboptimally stimulated 
lymphocytes in vitro also increased the specifi c humoral immune responses in vivo (Koenen et 
al., 2004). In mouse models of experimentally induced infl ammatory colitis, the strains inducing 
in PBMCs a higher release of IL-10, considered as anti-infl ammatory, and a lower release of 
IL-12, viewed as Th 1 stimulating, showed better in vivo protective ability against colitis (Foligne 
et al., 2007). Additionally, in vitro induction of infl ammatory cytokine production on DCs 
predicted the ability of diff erent Lactobacillus species to confer protection from induced colitis 
in mice (Mileti et al., 2009). In the latter study, strains displaying immunostimulatory properties 
exacerbated the development of induced colitis, emphasizing the need to characterize properly 
the in vivo immunomodulative properties of diff erent strains in various disease conditions. While 
these results indicate that the in vitro immunomodulatory responses observed for lactobacilli 
may indeed be predictive of in vivo functions, more comparative studies will be needed before 
any fi rm conclusions can be made.  
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3 Aims of the study
Th e objective of this study was to explore the possibility of using lactobacilli as health-promoting 
microbes and/or a recombinant vaccine vector in swine; to obtain host-specifi c Lactobacillus 
strains originating from the swine intestine as well as to characterize certain properties associated 
with probiosis of the strains and to evaluate the suitability of selected Lactobacillus strains for 
use as a viable probiotic / vaccine vector in swine. Additionally, the potential role of the surface 
layer proteins of Lactobacillus amylovorus strains in adhesion was examined. Th is study was part 
of a project aiming to develop a Lactobacillus vectored vaccine against porcine post-weaning 
diarrhea and edema disease caused by E. coli F18+ strains.
Th e specifi c aims of the subprojects were:
1. to examine the in vitro probiotic properties of lactic acid bacterial strains isolated from 
the feces and intestine of swine,
2. to evaluate the potential eff ects of Lactobacillus brevis ATCC 8287 as a feeding 
supplement on the performance and immune function in piglets, 
3. to evaluate the potential eff ects of a multispecies Lactobacillus supplementation 
(containing L. amylovorus, L. johnsonii, L. mucosae, L. salivarius and two strains of L. 
reuteri) on the performance and intestinal cytokine expression in piglets and
4. to characterize the putative probiotic properties of eight L. amylovorus strains and 
to assess the role of the surface layer proteins of the strains in adherence to porcine 
intestinal epithelium cells in vitro
Aims of the study
31
4 Materials and methods
4.1 Bacterial strains and culture condi? ons (I-IV)
A total of 94 LAB were isolated (I) from the digesta and feces of swine, with some of these 
Lactobacillus strains being used in further studies (III, IV). Digesta samples were from the 
duodenum, jejunum and ileum of six swine, and fecal samples from the rectum of two sows. For 
the isolation of swine Lactobacillus strains the samples were cultured on de Man Rogosa Sharpe 
(MRS) or Rogosa liquid and solid media (Difco, Becton-Dickinson (BD), USA) incubated 
anaerobically (Anaerocult A, Merck, Germany) at 37°C for 48 h. 
Six LAB isolates identifi ed as surface layer-carrying L. amylovorus strains were selected for 
Study IV (Table 5). Th e seven Lactobacillus strains used in the porcine feeding trial (II, III; Table 
5) were selected on the basis of the in vitro characteristics associated with probiotic properties. 
Additionally, several strains from culture collections were used (Table 5). Th e pathogens 
used in Study I and IV were selected based on food hygienic relevance and / or signifi cance to 
swine health. Furthermore, two Escherichia coli strains were used in the gene expression analysis 
in Study IV (Table 5).  
All bacterial strains were stored at −80°C; the LAB strains in MRS broth (Difco) and the 
pathogens and E. coli strains in tryptic soy broth (TSB; Difco) or in Luria-Bertani (LB) broth 
(Difco), containing 15% glycerol. 
Th e Lactobacillus strains (I-IV) were grown from stocks anaerobically in MRS broth at 37°C 
for 24h, and, when needed, subcultured in MRS solid media at 37°C for 48h.
Th e pathogenic bacteria used in the growth inhibition assay (I, IV) were grown from stocks 
in blood agar (Tammer-Tutkan maljat OY, Finland) or tryptic soy agar (TSA; Difco) at 37°C for 
24 h and subcultured in TSB. Th e enterotoxigenic E. coli (ETEC) strain used in the adhesion 
assays (IV) was cultured in LB broth (Difco). Th e broth cultures of the pathogens were incubated 
at 37°C with agitation (200 rpm). Th e E. coli strains used in the genome expression analyses (IV) 
were cultivated in LB broth or in M9ZB medium (Studier, 1991) with added kanamycin (30 μg/
ml) when appropriate. 
4.2 Iden? ? ca? on of lac? c acid bacteria (I, III)
Th e putative identifi cation of the porcine LAB isolates as members of the genus Lactobacillus 
(I) was performed with Gram-staining and a polymerase chain reaction-enzyme-linked-
immunosorbent-assay (PCR-ELISA) as described by Jakava-Viljanen and Palva (2007). 
LAB isolates confi rmed as S-layer positive (n=9) were identifi ed by 16S ribosomal RNA 
(rRNA) gene sequencing as described by Jakava-Viljanen and Palva (2007). For the remaining 
isolates, preliminary identifi cation down to the species level was performed by sequencing 
the fi rst 500 base pairs of the 16S rRNA gene. For selected isolates (n=11), sequencing of the 
whole 16S rRNA gene was performed in order to confi rm the preliminary identifi cation. Th e 
chromosomal DNA was extracted with standard methods, and the amplifi cation PCR product 
purifi ed with the Qiaquick PCR purifi cation kit (Qiagen Co., Germany). Th e primers used in 
the 16S rRNA sequencing analyses are listed in Table 6. Sequencing was performed with an 
ABI Prism 310 or 3700 Genetic Analyzer (Applied Biosystems Inc., USA), and the Basic Local 




In addition to sequencing of the 16S rRNA gene, whole genome sequencing (WGS) was 
performed to those Lactobacillus isolates used in Study III. Th e WGS was performed in the 
Institute of Biotechnology with the method described by Kant et al. (2011b). 
Table 5. Strains used in this work.
Strain Origin, reference or source Study
Lactobacillus strains
L. brevis ATCC 8287 Green fermented olives, ATCCa II
L. mucosae GLR 1167 (LAB 4) Swine feces, DVBc III
L. salivarius GRL 1169 (LAB 33) Swine ileum, DVBc III
L. johnsonii GRL 1171 (LAB 81) Swine ileum, DVBc III
L. reuteri GRL 1168 (LAB 26) Swine duodenum, DVBc III
L. reuteri GRL 1170 (LAB 49) Swine jejunum, DVBc III
L. amylovorus GRL 1112 (LAB 2) Swine feces (Jakava-Viljanen and Palva, 
2007), DVBc
III, IV
L. amylovorus GRL 1114 (LAB 8) Swine feces (Jakava-Viljanen and Palva, 
2007), DVBc
IV
L. amylovorus GRL 1115 (LAB 13) Swine ileum (Jakava-Viljanen and Palva, 
2007), DVBc
IV
L. amylovorus GRL 1116 (LAB 16) Swine jejunum (Jakava-Viljanen and 
Palva, 2007), DVBc
IV
L. amylovorus GRL 1117 (LAB 31) Swine jejunum (Jakava-Viljanen and 
Palva, 2007), DVBc
IV
L. amylovorus GRL 1118 (LAB 52) Swine jejunum (Jakava-Viljanen and 
Palva, 2007), DVBc
IV
L. amylovorus DSM 16698 Swine feces (Konstantinov et al., 2006b), 
DVBc
IV
L. amylovorus DSM 20531T Fermented corn silage, DSMb IV
Intestinal pathogens
Escherichia coli ERF 2014; O141, F18+ DVBc I, IV
Escherichia coli F4+ (ETEC) (Roselli et al., 2007) IV
Escherichia coli ATCC 43894; O157 (EHEC) ATCCa I, IV
Salmonella Typhimurium ATCC14028 ATCCa I, IV
Listeria monocytogenes R14-2-2 DVBc I, IV
Yersinia enterocolitica R5-9-1 DVBc I, IV
Strains used in gene expression studies
Escherichia coli DH5αF’ (Woodcock et al., 1989) IV
Escherichia coli BL21 (DE3) EMD Millipore IV
a American Type Culture Collection
b Deutsche Sammlung von Mikroorganismen
c Culture collection of the Department of Veterinary Biosciences / Veterinary Microbiology and 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.3 In vitro assays for examining probio? c proper? es
4.3.1 Acid and bile tolerance (I)
Th e ability of the LAB isolates to tolerate low pH and bile was determined by exposing each 
isolate (OD600: 1) to either pH-adjusted MRS broth (pH 2.0 or pH 4.0) or MRS broth containing 
0.3% ox gall. Th e isolates were incubated in these stress conditions for three hours at 37°C  in 
a microwell plate, aft er which a 7-step dilution series (dilution factor of 25) was generated in 
buff ered MRS (acid tolerance test) or regular MRS (bile tolerance test) on the same microwell 
plate. Five parallel series were used for each isolate. Following anaerobic incubation, the wells 
were examined for growth and the OD600 values were measured (iEMS Reader MF; Th ermo 
Labsystems, Finland). Th e size of the bacterial population surviving the exposure to each stress 
condition was estimated by the most probable number (MPN) method in MS Excel as described 
by Briones and Reichardt (1999). 
4.3.2 Bacterial adhesion (I, IV)
For the adhesion assay performed in Study I, intestinal epithelial cells were collected from 
healthy pigs aged two to three months. Th e entire intestine was divided to the anatomical 
sections (duodenum, jejunum, ileum, proximal colon and distal colon), and the sections were 
washed with PBS until clean. Th e enterocytes were removed by mechanical disruption, washed 
two to three times by centrifugation, and resuspended in Hanks Balanced Salt Solution (HBSS; 
Gibco BRL, Life Technologies Inc., USA) supplemented with lactalbumin (Difco), fetal bovine 
serum (Gibco BRL), dimethyl sulphoxide (DMSO; Sigma-Aldrich, USA) and glycerol, and 
stored at -80°C until used in the adhesion assay. For the assay, the enterocyte suspension and 
the OD-adjusted LAB isolates (OD600: 1) were incubated in a microwell plate, aft er which the 
unattached bacteria were removed by washing. Bacterial adhesion was quantifi ed by examining 
Giemsa-stained microscopic slides under a light microscope (Leica; Microsystems GmbH, 
Germany) and calculating the average number of attaching bacteria per enterocyte, using twenty 
visually undamaged enterocytes. In the case when the number of adhering bacteria in one 
enterocyte exceeded twenty, it was scored as twenty in the calculations, because in such cases it 
was too diffi  cult to calculate the exact number of bacteria. For each intestinal section, a positive 
and a negative control strain were selected from the isolates and the consistency of the adherence 
level of these was monitored in individual test runs.  
For the mucus adhesion assay conducted in Study IV, porcine intestinal mucus was isolated 
from the small intestine of a two-months-old piglet with a protocol modifi ed from MacAdam 
et al. (2000). Briefl y, the intestinal sections washed with protease inhibiting saline solution were 
scraped gently to collect the mucus, aft er which the insoluble material and cellular debris were 
separated by centrifugation. Th e crude mucus was homogenized, concentrated by fi ltration, and 
clarifi ed by centrifugation and several fi ltration steps. Purifi cation of the mucus was performed 
by gel fi ltration chromatography monitoring the A280 nm values of 5 ml fractions. Protein-
containing fractions were dialyzed against water and assayed for total protein by the method 
of Bradford (Bio-Rad Protein Assay, Bio-Rad, USA) using bovine serum albumin (BSA) as a 
standard, and for glycoproteins using the Crypton™ Glycoprotein Staining Kit (Th ermo Scientifi c, 
USA), with porcine gastric mucins (Sigma), horse radish peroxidase (HRP) and soybean trypsin 
inhibitor (Th ermo Scientifi c) as standards. Th e void volume fractions with high glycoprotein 
content were pooled, lyophilized and stored at -20°C until used in the adhesion assay. In addition 
to the porcine intestinal mucus, porcine gastric mucins (type II, Sigma) were used in the adhesion 
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assay. For the assay, the mucus was immobilized into polystyrene microtiter plate wells (Th ermo 
Scientifi c). Th e L. amylovorus cells used in the mucus adhesion assay were labelled with a nucleic 
acid binding fl uorescent stain by incubating the bacteria with SYTO®9 (Molecular Probes, USA), 
aft er which the OD-adjusted (OD600: 0.1, 0.25, 0.5 and 1.0) bacterial suspension was added to 
the mucus coated wells. Aft er incubation and removing the unbound bacteria by washing, the 
bound bacteria were lysed with sodium dodecyl sulfate (SDS) in NaOH, and the input (added) 
and output (remaining) fl uorescence values were measured in a microplate reader (Victor 
Multilabel Plate Reader; Perkin Elmer, USA). Th e background fl uorescence from mucus-coated 
wells without bacteria (for outputs) and from wells fi lled with PBS (for inputs) were subtracted 
from the values. Th e adherence was expressed as the proportion (%) of the original fl uorescence 
added.
 Th e cell adhesion assays conducted in Study IV were performed using IPEC-1 cells, a non-
transformed continuous cell line (Gonzalez-Vallina et al., 1996). Th e cells were cultured at 39 ºC 
and 5% CO2 using Dulbecco’s modifi ed eagle medium/Ham’s F12 Nutrient Mixture (DMEM/
Ham’s F-12 [1:1]) supplemented with fetal calf serum (FCS; Integro, Netherlands), insulin-
transferrin-selenium, HEPES (all PAN-Biotech, Germany) and epidermal growth factor (BD). 
In the assay, the cells were seeded (2 x 105 /ml) into a Transwell system (Th incerts™, 1 μm pore 
size, diameter 10 mm; Greiner bio-one, Germany) and allowed to diff erentiate for 4-5 days, until 
the transepithelial electric resistance (TEER) value was ≥1 kΩcm2. Th e L. amylovorus strains 
used in the cell adhesion assay were metabolically labelled with 3H-thymidine, and added to the 
wells aft er OD-adjustment (OD600: 0.25, 0.5 or 1). Aft er incubation, the unbound bacteria were 
removed by washing, the bound bacteria lysed with SDS in NaOH, and the radioactivity of the 
lysed samples (output) was measured by liquid scintillation counting. Th e input radioactivity 
values were determined by liquid scintillation counting of the OD-adjusted cell suspensions 
in DMEM/Ham’s F-12 [1:1] treated with SDS in NaOH. Th e adherence was expressed as the 
proportion (%) of the original radioactivity added aft er subtracting the background radioactivity 
from IPEC-1 cells incubated without bacteria (for outputs) and from DMEM/Ham’s F-12 [1:1] 
medium (for inputs).
4.3.3 Inhibi? on of pathogen adhesion (IV)
Th e ability of the L. amylovorus strains to inhibit the adhesion of the E. coli ETEC F4+ strain 
to IPEC-1 cells was investigated in the adhesion inhibition assay (IV). Th e ETEC strain was 
metabolically labelled with 3H-thymidine, and the expression of F4 fi mbriae was confi rmed 
with an agglutination test. Th ree diff erent setups were used in the adhesion inhibition assay, 
with diff ering orders of addition of the bacterial cells to the IPEC-1 cells: 1) exclusion, where the 
lactobacilli (OD600: 6) were allowed to adhere for 1 hour before adding the ETEC strain (OD600: 
0.6); 2) displacement, where the ETEC strain was allowed to adhere for 1 hour, and the unbound 
bacteria were removed with washing before the addition of lactobacilli; 3) competition, where 
both bacteria species were added simultaneously. In all of the assays, the cells were lysed aft er 
incubation and washing by SDS in NaOH, aft er which the radioactivity was measured by liquid 
scintillation counting. Th e proportion of adherent ETEC cells (%) in the presence or absence 
of the L. amylovorus strains was calculated as in the IPEC-1 cell adhesion experiments, and the 
inhibition (%) was calculated according to the formula: [adherence (no La) – adherence (with 
La)] / adherence (no La) x 100 %, where La indicates L. amylovorus.
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4.3.4 An? microbial ac? vity (I, III, IV)
Th e ability of the LAB isolates (I) and the L. amylovorus strains (IV) to inhibit the growth of 
selected intestinal pathogens was investigated with a turbidometric assay essentially as described 
by Skyttä and Mattila-Sandholm (1991), using fi ltration-sterilized (0.22 μm) spent culture 
fi ltrates (SCF) of the strains. Th e inhibitory eff ects of the SCF were examined by following the 
growth of the pathogens in TSB media supplemented (10% vol/vol) with the fi ltrates using an 
automatic reader Bioscreen C (Growth Curves Oy/Ab, Finland). Growth rate of the pathogens 
was quantifi ed using the area under the growth curve (AUC) value of the logarithmic growth 
phase, which was automatically processed by the soft ware (BioLink (Growth Curves Oy/Ab) or 
Research Express (Transgalactic Ltd., Finland)). Inhibition caused by the SCF was expressed as 
an area reduction percentage (ARP) calculated with the following formula: (AUCCo – AUCSCF) 
/ AUCCo × 100, in which AUCCo represents pathogen growth in TSB media supplemented with 
10% MRS medium and AUCSCF represents pathogen growth in TSB media supplemented with 
the culture fi ltrate. For each LAB strain assayed, one to three independent experiments with 
fresh SCF were performed, and in each assay two to three parallel wells were used. 
In order to estimate the relationship between the ARP value and CFU counts, ten-fold 
dilution series prepared from each of the pathogens were incubated in the Bioscreen microwell 
plate, the ARP values of the dilutions were plotted against the corresponding logCFU reductions 
and linear regression was used to generate regression formulas for the pathogens, as described by 
Skyttä and Mattila-Sandholm (1991). 
   Two diff erent approaches were adopted to monitor the eff ect of the fi ltrate pH on the 
pathogen growth inhibition. In the fi rst approach, the culture fi ltrates collected from the LAB 
strains were categorized into six pH groups, and for each group two diff erent pH controls were 
used in the Bioscreen assay: MRS medium with pH adjusted to the group mean either with lactic 
acid or with HCl. Th e second approach involved using both pH-adjusted (pH 6.2) and non-
adjusted culture fi ltrates. 
To verify the lack of antagonistic eff ects of the Lactobacillus strains used in Study III towards 
each other, the ability of each strain to grow in the presence of the SCF collected from the other 
strains was monitored with the turbidometric Bioscreen assay with a similar experiment setup as 
described for the intestinal pathogens.
4.3.5 S? mula? on of cytokine produc? on by dendri? c cells (IV)
Monocyte-derived dendritic cells (MoDC) were generated from purifi ed and in vitro cultured 
human monocytes using a method described by (Veckman et al. (2004) with minor modifi cations. 
Briefl y, peripheral blood mononuclear cells were fi rst isolated from leukocyte-rich buff y coats by 
two density gradient centrifugations and magnetic beading using anti-CD3 and anti-CD19 beads 
(Dynal Invitrogen, Life Technologies, USA). Th ereaft er, the monocytes were allowed to adhere 
to 24-well plates (Falcon, BD, Franklin Lakes, New Jersey) in the presence of RPMI 1640 (Sigma) 
supplemented with HEPES, penicillin, streptomycin and L-glutamine, and diff erentiation 
was induced by maintaining the cells in RPMI 1640 (with supplements as described above) 
containing FCS, human recombinant granulocyte macrophage-colony stimulating factor (GM-
CSF; Gibco Life Technologies, USA), and human recombinant IL-4 (Gibco Life Technologies). 
MoDCs were used on day 7 in the experiments, with cells of four donors being were used in 
each experiment. Th e OD-normalized L. amylovorus strains were added to human moDCs 
(multiplicity of infection (MOI) 1, 10, and 100), using medium without bacteria as a control. 
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Aft er incubation, the cell culture supernatants were collected and stored at -20°C until analyzed 
by Bio-Rad’s Bio-Plex Pro Cytokine assay using the Bio-Plex -200 platform (Bio-Rad, Hercules, 
CA). Quantifi cation of human TNF-α, IL-1β, IL-6, IL-10, and IL-12 was performed according 
to the manufacturer’s instructions. Human IP-10/CXCL10 was measured separately with the 
OptEIA ELISA kit (BD, Franklin Lakes, New Jersey) using samples diluted with sample matrix 
RPMI 1640 medium.   
4.3.6 An? microbial suscep? bility tes? ng (III)
Th e antibiotic resistance of the Lactobacillus strains used in Study III was investigated against 
fi ve antibiotics: G-penicillin, kanamycin, vancomycin, tobramycin and enrofl oxacin. Eight-
step dilution series (dilution factor of two) were prepared from the antibiotics in MRS to the 
honeycomb microwell plates (Growth Curves Oy/Ab), with the highest concentration of the 
antibiotic being as follows: 16 μg/ml for G-penicillin, 1024 μg/ml for kanamycin and vancomycin, 
512 μg/ml for tobramycin and 128 μg/ml for enrofl oxacin. Turbidity-adjusted lactobacilli (Mac 
Farland standard: 0.5) were inoculated (10% vol/vol) into the wells, and the growth of the strains 
was followed for 48h with a Bioscreen C (Growth Curves Oy/Ab). 
4.4 In vivo feeding trial (II, III)
4.4.1 Trial design and sample collec? on (II, III)
Th e bacterial strains used in the porcine feeding trial are listed in Table 5. For the trial, the cell 
density of L. brevis ATCC 8287 was adjusted to 1010 CFU/ml, and the cell density of each strain 
(n=6) included in the multispecies supplement was adjusted to 1.67 x 109 CFU/ml (total bacterial 
cell count 1010 CFU/ml). Th e density adjusted cell suspensions were aliquoted as 1 ml glycerol 
stocks, and stored at -80°C until used in the trial.
Th irty commercially-bred piglets of both genders (12 Finnish Landrace, 6 Finnish Yorkshire, 
and 12 backcrossing of Finnish Landrace X Finnish Yorksire sow and Finnish Landrace or 
Finnish Yorkshire boar) with mean body weights of 9.6 ± 1.7 kg were used in the trial. Aft er 
weaning at 4-5 weeks of age, the piglets were transported to the animal facilities of the National 
Veterinary and Food Research Institute EELA (later Finnish Food Safety Authority Evira). Based 
on litter origin, the piglets were divided into three groups (n=10), each of which was housed in 
similar but separate holding facilities and allowed to acclimatize for 12 days. During the three 
week feeding trial, the two treatment groups received daily a piece of wheat bun containing the 
thawed aliquot of the supplemented bacteria (L. brevis or the multispecies preparation), while 
the control group was provided with a wheat bun to which a 1-ml aliquot of PBS and glycerol 
had been added. Th e feeding trial was approved by the ethics committee of National Veterinary 
and Food Research Institute EELA (No 5/03).
Th e health status of the piglets as well as any signs of possible GI disturbances were 
monitored daily. Individual weighing as well as sample collection was performed according to 
the timeline shown in Figure 4. Serum was separated from the blood samples (II), and stored 
at -80°C. Fecal samples (II, III) were processed immediately for bacterial culturing or stored at 
-80°C for real-time qPCR. Aft er slaughtering, the intestinal luminal pH was measured (II, III) 
aft er which digesta samples were collected (II, III) from four compartments of the intestine; the 
jejunum (2-4 meters cranially from the ileocecal junction), the ileum (2 meters cranially from 
the ileocecal junction), the cecum, and the spiral colon, and stored at -80°C.  For the pathological 
investigation (II, III), pieces of intestinal walls were cut from the same compartments and 
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immersed in 10% buff ered formalin. Additionally, biopsies for immunofl uorescence studies 
(II) were also cut from the same locations, as well as from the jejunal and ileal Peyer’s patches, 
and stored at -80°C. For the cytokine assay (II, III), mucosal samples from the four intestinal 
compartments were scraped from the intestine wall with a scalpel, resuspended in the RNA 
stabilization reagent RNAlater (Ambion, USA), and stored at -20°C.
slaughter
day -12 -8 0 2 9 20, 21,22,23
sample W B F W W W, F, B, IC, IM, IB
feeding
timelineweek 1 week 2 week 3
Figure 4. Weighing and sample collection schedule during the porcine feeding trial. W = 
weighing, F = fecal sample, B = blood sample, IC = intestinal contents (digesta) sample, IM 
= intestinal mucosal sample, IB = intestinal biopsy sample
4.4.2 Detec? on of the supplemented strains in intes? nal and fecal samples (II, 
III)
Culture techniques were used to investigate if the lactobacilli strains fed to the piglets would be 
able to survive through the porcine intestine (II, III). Prior to culturing, pooled fecal samples were 
generated by combining either all ten individual pre-feeding samples within the study groups or 
two to four individual samples per group from pigs that had been slaughtered on the same day. 
Pooled samples were cultured in MRS liquid and solid media, and colonies with a morphology 
resembling the supplemented strains were selected; 14 colonies from the pre-feeding samples 
from each group, as well as 30 (control and multispecies groups) and 42 (L. brevis group) colonies 
from the slaughter samples. Th e isolates were identifi ed with species-specifi c PCR analysis using 
Dynazyme II DNA Polymerase and primers listed in Table 6. 
To confi rm the identity of the fecal isolates, some of the PCR products were further selected 
for sequencing (III). Th e purifi ed PCR products were sequenced with the original amplifi cation 
primers and Big Dye Terminator v3.1 Cycle Sequencing Reaction Kit (Applied Biosystems, USA). 
Aft er precipitating and washing, the PCR products were resuspended in Template suppression 
reagent (Applied Biosystems, USA) and evaluated by ABIPrism 310 Genetic Analyzer (Applied 
Biosystems). Th e sequences obtained were analyzed by comparison with the GenBank sequence 
fi le. 
To determine whether the fecal isolates represented the same strains as those fed to the 
piglets, selected isolates were further analyzed with pulsed-fi eld gel electrophoresis (PFGE), 
essentially as previously described by Vihavainen and Björkroth (2009) (III). Agarose embedded 
bacterial cells were lysed with lysozyme (Sigma, USA), mutanolysin (Sigma) and proteinase K 
(Finnzymes), aft er which the DNA was digested with SmaI endonuclease (New England Biolabs, 
USA). Th e separation of restriction fragments was performed on SeaKem Gold agarose (Lonza 
Rockland) at 14°C and 6 V/cm with the PFGE switching and running times as follows: 0.5-6 s 
and 16 h (L. reuteri); 0.5-10 s and 16 h (L. johnsonii); 0.5-15 s and 18 h (L. mucosae); 0.5-20 s and 
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20 h (L. amylovorus and L. salivarius). Images of ethidium bromide-stained gels were captured, 
and the pattern similarity was estimated visually. Th e image of L. reuteri run was imported into 
BioNumerics (version 5.1; Applied Maths, Sint-Martens-Latem, Belgium), the gel was normalized 
against the low-range PFG marker (New England Biolabs), and a dendrogram of PFGE patterns 
was constructed using the unweighted pair group method with arithmetic averages (UPGMA) 
and the band based Dice similarity coeffi  cient with a position tolerance of 1.8%.
Th e levels of the fed L. brevis strain in the digesta samples as well as in the fecal samples 
taken at slaughter were analyzed with real-time qPCR (II) using the same S-layer gene-fl anking 
primers as employed in the analysis of the isolates cultured from the fecal samples. Th e bacterial 
cell lysis, DNA isolation and real-time qPCR amplifi cations were performed as described in 
section 4.4.3. Ten-fold dilution series of 0.1 pg to 10 ng of L. brevis genomic DNA were used as 
standards in conjunction with the intestinal DNA samples in the same real-time qPCR run. 
Indirect immunofl uorescence assay (IFA) was used to localize the L. brevis cells in diff erent 
intestinal compartments (II). Th in-sections cut from the Tissue-Tek O. C. T. (Sakura Finetek, 
USA) embedded frozen intestinal wall pieces were fi xed with paraformaldehyde and treated 
with a blocking solution containing BSA (Sigma Life Sciences, USA) and incubated with rabbit 
anti-SlpA serum. Aft er removing unbound antibodies by washing, further incubation with goat 
anti-rabbit Alexa Fluor 488 F(ab’)2 Fragment secondary antibody (Life Technologies, USA) was 
performed, aft er which the sections were embedded in ProLong Gold Antifade Reagent (Life 
Technologies, USA) including DAPI (4’, 6-diaminido-2-phenylindole dilactate) nucleic acid stain 
for recognizing epithelial cell DNA. A Leica DM 4000 B microscope (Leica Microsystems, USA) 
equipped with epifl uorescence excitation modules was used to examine the stained sections. Th e 
presence of L. brevis was determined by two independent investigators counting those fl uorescent 
bacteria that resembled the L. brevis cell staining morphology in 20 randomly selected fi elds (in 
three to fi ve sections) at 400x magnifi cation. Controls were obtained by omitting the primary 
antibody. For histological clarity parallel sections were stained with hematoxylin and eosin. 
Confocal images were taken with a Leica TCS SP5 microscope (Leica Microsystems, Germany) 
using the Leica Application Suite Advanced Fluorescence Lite 2.6.0 (LAS AF Lite; Leica, 
Germany) soft ware. Th e images were studied with the public domain soft ware Image J. 
4.4.3 Quan? ? ca? on of total bacteria and the genus Lactobacillus from 
digesta and fecal samples (II, III)
Th e fecal and intestinal digesta samples collected from the piglets at slaughter were analyzed for 
the abundance of total bacteria (II, III) and the genus Lactobacillus (III) with real-time qPCR. 
Bacterial cells were collected from the digesta or feces by centrifugation, lysed by incubation with 
proteinase K, and disrupted by bead beating twice in a FastPrep®-24 cell disruption instrument 
(MP Biomedicals, Inc., USA) with sterile glass beads (Ø=0.1 mm; Scientifi c industries inc., 
USA). Genomic DNA was isolated from the samples by phenol-chloroform-isoamyl alcohol 
extraction and chloroform-isoamyl alcohol purifi cation with standard methods. Th e template 
DNA was diluted 1:1000 or 1:100 for the real-time qPCR amplifi cations performed with the 
primers listed in Table 6, and SYBR Green Master Mix (Roche Diagnostics, Germany). A melting 
curve analysis was carried out in conjunction with each amplifi cation run by slowly cooling from 
95°C to 60°C, with fl uorescence collection at 0.3°C intervals. Ten-fold dilution series of 0.1 pg 
to 10 ng of L. crispatus genomic DNA were used as a standard in conjunction with the intestinal 
DNA samples in the same real-time qPCR run.   
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4.4.4 Detec? on of serum immunoglobulins by ELISA (II)
Serum samples taken before the start of the feeding trial and at slaughter were analyzed for total 
IgA and IgG concentrations using a commercial pig IgA or IgG ELISA Quantitation Kit (Bethyl 
Laboratories, USA), according to the manufacturer’s instructions. Two-fold serial dilutions were 
prepared from the serum samples (from 1:400 to 1:6400 for IgA and from 1:20 000 to 1:160 000 
for IgG). Th e dilutions of HRP conjugate used in the assays were 1:120 000 for IgA and 1:20 
000 for IgG. Th e optical density at 450 nm was measured with a Multiskan EX device (Th ermo 
Scientifi c, Finland) and Sigmoid logistics was utilized to calculate the Ig concentrations of the 
samples from the linear range of the calibration curve (Ascent Soft ware for iEMS and Multiskan 
EX; Th ermo Scientifi c, Finland). 
L. brevis-specifi c IgG antibodies were determined from the serum samples taken at 
slaughter with a whole-cell ELISA method essentially as described by Lindholm et al. (2004). 
Briefl y, frozen pellets of L. brevis cells were resuspended in serum samples diluted in PBS (1:10) 
and then incubated. Th e unbound antibodies were removed by washing, and 1:1000 diluted 
HRP-conjugated goat anti-pig IgG (Bethyl Laboratories) was added. Aft er incubation and 
washing, the cells were resuspended in substrate buff er and loaded on microwell titer plates. 
3,3’,5,5’-Tetramethylbenzidine (TMB; Sigma, Germany) was used as the substrate solution as 
described by Laitinen et al. (2002). Th e concentration values of specifi c IgG were expressed as 
arbitrary units (AU) per milligram total IgG.
4.4.5 Cytokine gene expression in the intes? nal mucosa (II, III)
Preliminary analysis of the expression of selected immunological genes in the intestinal mucosal 
samples of fi ve piglets from both the control group and the L. brevis supplementation group (II) 
was performed essentially as described by Solano-Aguilar et al. (2008). Th e genes chosen for 
the analysis included those of cytokines (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p35, IL12p40, 
IL-18, TNF-α, IFN-α, IFN-?), immunological receptors (TLR-9, IL-12-RB2), and the adapter 
protein MyD-88 as well as the transcription factor NF-?B. Total RNA was extracted from the 
homogenized mucosal samples with a phenol/chloroform-based method (Trizol reagent; 
Invitrogen, USA), aft er which the samples were treated with DNase in the presence of RNase 
inhibitor (Ambion, USA). Th e absence of genomic DNA was confi rmed with a real-time qPCR 
amplifi cation of the ribosomal protein L32 (RPL32) housekeeping gene. Quantifi cation of the 
RNA was performed using Bioanalyzer 2100 and the RNA 6000 Kit (Agilent Technologies, USA), 
and  7.5-10 μg of RNA was used for cDNA synthesizing with SuperScript II RT (Invitrogen) and 
oligo(dT) (Invitrogen), with 50 ng of this cDNA being used for the real-time qPCR amplifi cations 
performed with an iCycler iQ Real-Time Detection System (Bio-Rad, USA). Th e primers 
and probes used in the real-time qPCR runs can be found in the DGIL Porcine Translational 
Research Database available at http://www.ars.usda.gov/services/docs.htm?docid=6065. Data for 
each gene assayed were adjusted for the housekeeping gene RPL32, and the adjusted values were 
analyzed using the ??CT method (Livak and Schmittgen, 2001), with control group piglets as the 
comparison group.
Th e gene expression levels of eight selected cytokines, i.e., IL-1β, IL-4, IL-6, IL-8, TGF-
β1, IFN-α, IFN-γ and TNF, were further analyzed (II, III) with the QuantiGene 2.0 Plex 
Assay (Aff ymetrix/Panomics, USA), according to the manufacturer’s instructions. Th is assay 
combines branched DNA signal amplifi cation and multianalyte bead technologies, and enables 
quantifi cation of mRNA signals without an RNA isolation step.  Homogenization of the samples 
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was done in a homogenization solution (QuantiGene 2.0 Sample Processing Kit; Aff ymetrix/
Panomics) using a FastPrep®-24 instrument (MP Biomedicals, Inc.) with a CryoPrep adapterTM 
(MP Biomedicals, Inc.) and zirconium–silica beads (Ø=0.1 mm; Biospec Products, USA). Aft er 
incubation at 65°C, the supernatants were collected with centrifugation and used in the assay. 
Samples were run with a Bio-Plex 200 array system (Bio-Rad Laboratories, USA) using the low 
RP1 target values. Aft er subtracting the background fl uorescence from the values obtained for 
the test samples, each gene marker was normalized to the geometric means of hypoxanthine 
phosphoribosyltransferase 1 (HPRT1) and peptidyl-prolyl cis-trans isomerase B (PPIB) 
housekeeping genes. Normalized values were averaged for treatment groups, and the fold change 
calculated using the control group as the comparison. 
4.5 The surface layer proteins of Lactobacillus amylovorus strains (IV)
4.5.1 Genes encoding the S-layer proteins: Detec? on and expression analysis 
(IV)
Th e putative slp genes were identifi ed in silico in the draft  genomes of the L. amylovorus strains 
based on homology with L. acidophilus slp gene sequences. Standard SDS-PAGE analysis of the 
L. amylovorus strains was used to estimate the molecular weights of the S-layer proteins. Th e 
expressed slp genes were identifi ed on the bases of these molecular weights, and additionally, 
using aminoterminal sequencing and/or peptide mapping analysis performed at the Institute of 
Biotechnology (University of Helsinki, Finland). 
4.5.2 Adherence of the S-layer protein-coated cell wall fragments (IV)
Th e role of the L. amylovorus Slp:s in adherence to IPEC-1 cells was examined using a protein 
presentation system based on purifi ed L. amylovorus cell wall fragments (CWF) as S-layer 
protein carriers.  Th e S-layer proteins used in the adhesion assays were produced by cloning 
the expressed slp genes as NcoI-XhoI –fragments in E. coli DH5αF’ and expressing the proteins 
in E. coli BL21 (DE3) as C-terminal hexahistidine tag-fusions, as described in the pET system 
manual (Merck KGaA, Germany) and as previously reported by Åvall-Jääskeläinen et al. 
(2008). Th e oligonucleotide sequences used in the PCR reactions, carried out with Phusion 
High-Fidelity DNA polymerase (Th ermo Scientifi c), are listed in Table 6. Aft er purifi cation 
with His Trap HP columns (GE Healthcare, UK), the pooled protein fractions were dialyzed 
against deionized water, centrifuged and stored in aliquots at -80°C until used to coat the cell 
wall fragments (CWF) purifi ed from the L. amylovorus cells as described by Åvall-Jääskeläinen 
et al. (2008).  Before coating, the recombinant S-layer proteins were solubilized in guanidine 
hydrochloride (GuHCl), dialyzed, and centrifuged to remove large protein aggregates. Aft er 
incubating the S-layer proteins with the CWF (ratio 1:4 (W/W)), the coated CWF were collected 
by centrifugation and analyzed by SDS-PAGE in order to estimate the success of the coating. 
Th e absence of large protein aggregates was verifi ed by examining the uranyl acetate stained 
preparations by JEOL 1200-EX II transmission electron microscope. Th e uncoated CWF used 
as controls were labeled by EZ-Link Sulfo-NHS-LC-Biotin (Th ermo Scientifi c, Waltham, 
MA) according to the manufacturer’s instructions. Th e Slp-coated or uncoated CWF were 
added to the IPEC-1 cells grown on Th incert™ wells and incubated, aft er which the unbound 
material was removed by washing and the IPEC-1 cells were fi xed with paraformaldehyde. 
Th e Slp-coated CWF were detected by indirect immunofl uorescence staining with Slp-specifi c 
immunoglobulins (GE Healthcare, UK) and AlexaFluor488-conjugated secondary antibodies 
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(Life Technologies), and the uncoated cell walls were detected by staining with AlexaFluor488-
conjugated streptavidin (Life Technologies). Th e bottoms of the Th incert™ wells were observed 
in a Leica DM 4000B epifl uorescence microscope (Leica Microsystems, Wetzlar, Germany). Th e 
mean number of adherent CWF was quantifi ed from 20 randomly selected fi elds of 3.5 x 104 
μm2, and representative photographs were taken with the Olympus DP70 digital camera system 
with the cellP imaging soft ware (Olympus Corp., Tokyo, Japan).
4.6 Sta? s? cal analyses (I-III)
SPSS versions 12.0.1 (I), 18.0 (II) or 21.0 (III) for Windows (SPSS Inc., Chicago, IL, USA) were 
used for statistical analysis of the data. As the tests of normality showed that the data did not 
follow a normal distribution (I), or the datasets were too small to assess the distribution (II  , 
III), nonparametric tests were utilized in the analyses. Th e p-values ≤ 0.05 were considered 
signifi cant. 
In order to estimate diff erences between several test groups, the Kruskall-Wallis test (for 
independent samples) or Friedman’s test (for dependent samples) was applied (I), with suitable 
post hoc analysis. When appropriate, the Bonferoni correction was used when estimating 
statistical signifi cance. Diff erences between two test groups were estimated with the Mann-
Whitney U test (I, II, III), or, for related samples within the groups, the Wilcoxon Signed-Rank 
test (II). For categorical data, cross-tabulation with Pearson Chi-Square test or Fisher’s exact test 
was used (I). Principal component analysis (PCA) was used to reduce the dimensions of the 
data when the antimicrobial assay results were interpreted (I), and regression formulas for the 
relationships between ARPs and CFU counts were calculated for each indicator organism used in 
the antimicrobial activity tests (I, IV).
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5 Results and discussion
5.1 Isola? on and iden? ? ca? on of lac? c acid bacteria (I, III)
In total, 29, 26, 31 and 8 LAB strains were isolated from the swine duodenum, jejunum, ileum 
and feces, respectively. Th e isolates were putatively identifi ed as Lactobacillus strains with a PCR-
ELISA assay, and partial sequencing of the 16S rRNA gene confi rmed this identity for 89 isolates, 
while fi ve of the isolates were identifi ed as Streptococcus alactolyticus (GenBank accession 
numbers for the best BLAST hits are shown in Table 1 in I). Th e identifi cation of 11 isolates 
was further confi rmed with sequencing of the whole 16S rRNA gene. Th e largest identifi cation 
groups were L. reuteri (n=46), L. salivarius (n=14), L. mucosae (n=10), L. johnsonii (n=8) and 
L. amylovorus (n=6), all of which have previously been identifi ed as abundant phylotypes in the 
swine intestinal microbiota (Leser et al., 2002; Mann et al., 2014). 
For the swine originating strains used in the in vivo feeding trial (Study III), the WGS 
confi rmed the preliminary identifi cation based on 16S rRNA sequencing (Kant et al., 2011b, 
personal communication Kant R.). 
5.2 In vitro probio? c proper? es
5.2.1 Acid and bile tolerance (I)
Th e results of each stress tolerance test were categorized initially into four classes: good, 
moderate, poor and no survival (Table 7). For the Pearson Chi-Square test analysis of the acid 
tolerance test results, the categories of moderate and good survival were combined, as were the 
categories of poor or no survival to minimize the number of cells with an expected count less 
than fi ve in the cross tabulation table.   
Th e majority of the isolates tolerated exposure to bile and pH 4.0 well with no signifi cant 
reductions in MPN values, whereas more variation in tolerance to pH 2.0 was observed   (Table 
7). Th is is in line with previous studies performed with lactobacilli of swine origin, reporting 
typically good tolerance to pH 3.0 to 4.0, whereas pH 2.0 has been more poorly tolerated by the 
isolates (De Angelis et al., 2006; Yun et al., 2009; Guo et al., 2010; Zhang et al., 2013). Considering 
the infl uence of the isolation site of the strain on the acid and bile tolerance, strains sourced from 
the human GI tract have been reported to tolerate low pH and bile better than those originating 
from other environments (Morelli, 2000; Upadrasta et al., 2011). However, to the knowledge 
of the author, the putative diff erences between strains isolated from diff erent intestinal 
compartments have not been investigated previously. In this work, the intestinal isolates tended 
to tolerate pH 2.0 better than the fecal isolates (Pearson Chi-Square p=0.062), but the tolerance 
to pH 4.0 (Pearson Chi-Square p=0.247) or to bile (Pearson Chi-Square p=0.943) did not diff er 
according to the isolation sites. At the species level, the largest identifi cation group, namely L. 
reuteri, tolerated pH 2.0 (Fisher’s exact test p<0.0005) and bile (Fisher’s exact test p=0.004) better 
than the others, but no such diff erence was observed with respect to pH 4.0 tolerance (Fisher’s 
exact test p=0.361). However, there was extensive variation between strains of the same species, 
a phenomenon observed also in other studies comparing multiple strains of one single species 
isolated from various environments, including swine intestine and diff erent foodstuff s (Parente 
et al., 2010; Zhang et al., 2013). Although specifi c strains of L. reuteri isolated from swine have 
been previously shown to be resistant to exposure to low pH and bile (Lee et al., 2009; Guo et 




Table 7. Proportion (%) of the lactobacilli isolates in each stress survival category according to the 
origins of the isolates. Th e values in brackets represent the number of isolates.
Stress survival  category






















































































0 0 0 87.5 
(7)
0 0
a no reduction in the MPN value compared with the control
b a maximum of 3 logs reduction in the MPN value
c a maximum of 6 logs reduction in the MPN value
d more than 6 logs reduction in the MPN value
5.2.2 Adhesion (I, IV)
Th e adhesion capacity of the LAB isolates to swine enterocytes collected from the small intestine 
(i.e. duodenum, jejunum and ileum) as well as from the large intestine (i.e. proximal and distal 
colon) was very variable (Table 2 in I), with better adherence to the colonic enterocytes compared 
to those from small intestinal origin (Friedman test p<0.001; Fig. 1 in I). Examples of adherent 
and non-adherent strains are shown in Figure 5. Th e high strain-to-strain variability with respect 
to lactobacillar adherence has also been observed in previous studies (Lin et al., 2007; Guo et al., 
2010), but the possible variation in adhesion to enterocytes collected from diff erent intestinal 
sections has rarely been addressed before this study. Barrow et al. (1980) observed that two swine 
originating LAB isolates (identifi ed as L. fermentum and Streptococcus salivarius) adhered to 
the squamous epithelial cells of the mouth, esophagus and stomach, but not to the columnar 
epithelium of the stomach, duodenum, ileum or cecum. In addition, Li et al. (2008) compared 
intestinal mucus isolated from the three compartments of the small intestine (i.e. duodenum, 
jejunum and ileum) in terms of lactobacillar adhesion, and adhesion to ileal mucus was found 
to be more effi  cient than that to duodenal or jejunal mucus. In addition to the origin of the 
enterocytes, also the isolation site of the strain could aff ect its adherence pattern, and better 
adhesion to that part of the intestine from which the strain was originally isolated might be 
anticipated. While some previous studies have described these kinds of adhesion preferences 
(Barrow et al., 1980; Jin et al., 1996), in this study the origin of the isolate did not seem to 
infl uence its adhesion properties to enterocytes collected from the diff erent intestinal sections.
At the species level, those isolates identifi ed as L. reuteri showed a generally good adherence 
capacity, with a statistically signifi cantly higher level of adhesion to duodenal enterocytes 
compared to L. amylovorus and L. mucosae (Kruskall-Wallis p=0.05; Fig. 2A in  I). In addition, 
the adhesion of L. reuteri isolates to the proximal colon cells was better than that of L. johnsonii 
or L. amylovorus isolates (Kruskall-Wallis p=0.024; Fig. 2D in I) and to the distal colon cells 
better than that of L. johnsonii isolates (Kruskall-Wallis p=0.032; Fig. 2E in I). Although certain 
strains of L. reuteri have shown very good in vitro adherence to diff erent intestinal cells (Guo et 
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al., 2010; Zhao et al., 2012; Zhang et al., 2013), no proper comparison to other species has been 
performed. 
Th e adhesion capacity of the L. amylovorus isolates (n=8) to porcine mucus as well as to 
IPEC-1 cells were further characterized. All of these strains showed relatively poor adherence to 
porcine gastric mucins as well as to isolated intestinal mucus of swine origin, as typically around 
1% to 2% of the original amount of cells remained mucin-bound (Fig. 1 in IV). In previous studies 
strains with such a low-level adherence have been considered as non-adhering (Kirjavainen et 
al., 1998; Ouwehand et al., 1999; Collado et al., 2005). In addition, the lack of consistent dose-
response of binding, and the high variability in diff erent replications of the adhesion experiments 
point to non-specifi c binding due to hydrophobic interactions, which are known to interfere with 
interpretation of mucus binding studies (Laparra and Sanz, 2009; Van Tassell and Miller, 2011). 
Despite the lack of mucus binding, the L. amylovorus GRL-strains have previously been shown to 
adhere to ECM proteins (Jakava-Viljanen and Palva, 2007). Th e adherence of the L. amylovorus 
strains to IPEC-1 cells showed more variability as well as dose-responsivity in comparison to 
the mucus adhesion results.  Th e previously reported adhesion of L. amylovorus DSM 16698 
(Roselli et al., 2007) was confi rmed, and the adhesion of strains GRL 1112 and GRL 1115 was at 
a similar level (Fig. 2 in IV). When comparing the adhesion results obtained for the GRL-strains 
determined with either IPEC-1 cells or isolated porcine enterocytes, it seems that that these 
methods do not correlate well with each other. Th ose strains displaying the highest adhesion 
ability to IPEC-1 cells (namely GRL 1112 and GRL 1115) were poorly adhesive to isolated small 
intestinal enterocytes, although strain GRL 1115 adhered strongly to colonic enterocytes (Table 
S1 in I). On the other hand, the strain exhibiting the best adherence to the enterocytes isolated 
from the small intestine (namely GRL 1114; Table S1 in I), adhered only weakly to the IPEC-1 
cells (Fig. 2 in IV).
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Figure 5. Examples of adhering (A, B) and non-adhering (C, D) lactobacilli. Enterocytes 
collected from porcine duodenum (A) and ileum (B-D).
5.2.3 Inhibi? on of pathogen adhesion (IV)
Th e ability of the L. amylovorus strains to inhibit the adhesion of E. coli ETEC F4+ to IPEC-1 
cells was investigated with three diff erent experimental set-ups (i.e. competition, exclusion and 
displacement). In both the competition and in the exclusion assays, four of the L. amylovorus 
strains (DSM 16698, GRL 1112, GRL 1115 and GRL 1118) were able to clearly inhibit the 
adhesion of the E. coli ETEC F4+ (Fig. 3A and 3B in IV), but no inhibition of ETEC adhesion 
was detected in the displacement assay (Fig. 3C in IV). Several previous studies have evaluated 
the ability of lactobacilli to inhibit pathogen adhesion (Jin et al., 2000; Fernandez et al., 2003; 
Bogovic Matijasic et al., 2006; Collado et al., 2007; Dhanani and Bagchi, 2013; Zhang et al., 
2013), and these three diff erent set-ups have commonly been used. In the competition assay, 
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simultaneous addition of the Lactobacillus and the pathogen will result in competition for the 
previously empty binding sites, while the other two set-ups explore the possible displacement 
of previously bound bacteria. In the exclusion assay, Lactobacillus cells are allowed to bind to 
the target before the addition of the pathogen, while the reversed order of adding the diff erent 
bacteria is used in the displacement assay. When considering that lactobacilli are normal residents 
of the swine intestinal microbiota, i.e. they are continuously present, whereas the presence of 
pathogens is usually transient in the swine gut, it may be that the exclusion assay which assesses 
the ability of lactobacilli to protect intestinal cells from becoming colonized by pathogens is 
the most appropriate simulation of the in vivo situation. Moreover, it might be anticipated that 
the greatest inhibition of pathogen adhesion by lactobacilli would be obtained in the exclusion 
and / or competition assays, while displacement of pathogens already attached to the intestinal 
structures would be less likely to occur. Indeed, this was observed with the L. amylovorus strains 
used here, as inhibition of ETEC adhesion was observed in the competition and exclusion assays, 
but none of the strains were able to remove previously bound ETEC from IPEC-1 cells. A higher 
inhibition of pathogen adhesion in the exclusion and / or competition assays compared to the 
displacement assay has been noted also in some previous studies (Jin et al., 2000; Fernandez et 
al., 2003; Bogovic Matijasic et al., 2006; Zhang et al., 2011), but not in others (Collado et al., 2007; 
Dhanani and Bagchi, 2013).
As competition for the same adhesion sites is believed to be one mechanism behind 
pathogen exclusion, the ability to inhibit the adhesion of pathogens could be expected to correlate 
with adhesiveness of the strain. To some extent, this was the case with the L. amylovorus strains 
used in this study, as three (namely DSM 16698, GRL 1112 and GRL 1115) of the four strains 
which inhibited ETEC adhesion also exhibited adhesion ability to IPEC-1 cells. Th e inhibition 
of pathogen adhesion demonstrated by the poorly adherent strain GRL1118 suggests that in 
addition to competition for adhesion receptors other mechanisms must also be involved in the 
inhibition. Th ese could include coaggregation with the pathogen or secreted inhibitory factors 
(Lebeer et al., 2008). Th e culture fi ltrate of the strain GRL 1118 did not inhibit the growth of the 
ETEC strain more than those of the other GRL strains (see 5.2.4), but the possible production of 
substances specifi cally capable of inhibiting adherence was not investigated. 
5.2.4 An? microbial ac? vity against intes? nal pathogens (I, IV)
Th e spent culture fi ltrates collected from the LAB isolates were assayed against six indicator 
pathogens (I, unpublished results). Th e growth inhibitions caused by the SCF were quantifi ed 
using the area under the growth curve (AUC) value, which combines several points of time in the 
indicator growth curve, and has been shown to be a reliable parameter for determining changes 
occurring during bacterial growth (Skyttä and Mattila-Sandholm, 1991). Th e log CFU reductions 
in pathogen numbers caused by the culture fi ltrates were estimated using the regression formulas 
generated for each pathogen.
In accordance with previous studies estimating the antimicrobial properties of porcine 
lactobacilli (du Toit et al., 2000; Chang et al., 2001; De Angelis et al., 2006; Kim et al., 2007; Lin et 
al., 2007; Guo et al., 2010; Klose et al., 2010a; Klose et al., 2010b), a variable degree of inhibition 
in the growth of the indicator pathogens was caused by the SCF collected from the porcine 
LAB (I, unpublished results).  When the diff erent indicator pathogens were compared against 
each other, E. coli ETEC F4+ and E. coli EHEC were inhibited statistically signifi cantly more 
than the other pathogens (Friedman test p<0.001; Fig. 6). Th e culture fi ltrates of the eight L. 
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amylovorus strains were also assayed against the same pathogens (IV), and similarly, the growth 
of E. coli ETEC F4+ was the most effi  ciently inhibited by these SCF (Fig. 4 in IV). As far as is 
known, the magnitude of growth inhibition exhibited by diff erent indicator pathogens has not 
been systematically compared previously, but strains of E. coli have been extensively inhibited by 
lactobacilli also in other studies (Guo et al., 2010; Klose et al., 2010a).
E. coli F18 E. coli F4 E. coli EHEC S. Typhimurium Y. enterocolitica
E. coli F4 0.000
E. coli EHEC 0.002 0.000
S.Typhimurium 0.504 0.000 0.000
Y. enterocolitica 1.000 0.000 0.001 0.880
L. monocytogenes 1.000 0.000 0.016 0.107 1.000
Figure 6. A box-and-wishkers plot illustrating the log CFU reductions achieved by the six 
indicator pathogens cultured in TSB media supplemented with the SCF collected from the 
porcine LAB isolates. Each box shows the median, quartiles and extreme values within 
a category. Friedman’s test post hoc values for pairwise comparisons (SPSS, 2012) with a 





For most of the indicator pathogens, the isolation site of the LAB strain did not infl uence the 
growth inhibition caused by the SCF, except for E. coli EHEC and L. monocytogenes, both of which 
were inhibited more by the fecal isolates (Kruskal-Wallis p=0.037 (E. coli EHEC) and p=0.016 
(L. monocytogenes); Fig. 7). However, the small number of fecal isolates as well as the fact that 
these isolates represented diff erent Lactobacillus species compared to the intestinal isolates may 
have infl uenced this fi nding. At the species level, when comparing the fi ve largest Lactobacillus 
identifi cation groups, a statistically signifi cant diff erence was found in the inhibition of all the 
indicator pathogens (Kruskall-Wallis p<0.001). Generally, the isolates identifi ed as L. salivarius, 
L. johnsonii or L. amylovorus inhibited the indicator pathogens more than the isolates identifi ed 
as L. reuteri or L. mucosae (Fig. 8). Apparently, no systematic comparisons of diff erent species of 
lactobacilli in terms of pathogen growth inhibition have been performed previously, but three 
L. salivarius strains have been found to inhibit several swine pathogens, including fi ve E. coli 
strains and a Brachyspira pilosicoli strain, generally more than the other Lactobacillus species 
investigated (Klose et al., 2010a)  
Th e pH of the culture fi ltrates collected from the LAB isolates (I), and from the L. amylovorus 
strains (IV) varied from 3.62 to 5.36 and from 3.8 to 4.5, respectively.  In order to assess the eff ect 
of the pH value of the SCF on the pathogen growth inhibition, two diff erent experimental set-
ups were used. In Study I, the pathogen growth inhibition evoked by the SCF was compared to 
those caused by the pH controls (MRS medium with pH adjusted with lactic acid or with HCl). 
It was evident that most of the growth inhibition caused by the SCF was due to lactic acid and 
low pH, but certain fi ltrates inhibited the growth of the indicators more than the pH controls 
(Table S1 in I). Th us, some of the LAB isolates appeared to produce other inhibitory substances 
in addition to organic acids. On the other hand, the pathogen growth inhibition caused by the 
pH-adjusted (pH 6.2) SCF of the L. amylovorus strains (IV) was low, indicating that most of 
the pathogen growth inhibition was due to acidity of the SCF (data not shown). Alternatively, 
inhibitory compounds with activity at acidic but not at neutral pH might have been produced, 
as has been observed for Lactocin S produced by Lactobacillus sakei (Mortvedt-Abildgaard et 
al., 1995). Th ese results are in line with previous studies showing that neutralization of the SCF 
oft en, although not invariably, abolishes the growth inhibition of pathogens caused by the fi ltrate 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.2.5 Correla? ons between the proper? es tested (I)
Th e possible association between the antimicrobial activity, adherence to the enterocytes and 
stress tolerance of the LAB strains was investigated with the Spearman’s rank-correlation test. 
For this analysis, a relative survival was calculated from the stress tolerance data of each isolate 
with the following formula: MPN (stress) / MPN (control), and the logarithmic of this value was 
used in the correlation analysis. Additionally, an overall average adhesion was calculated for each 
isolate from the adhesion values to enterocytes of diff erent intestinal origins. In an attempt to 
reduce the dimensions of the antimicrobial activity data, a principal components analysis (PCA) 
was performed. In the correlation matrix, all variables had correlation coeffi  cients greater than 
0.68, indicating that the correlations between the diff erent variables were suffi  cient to include 
all of the variables in the analysis. Th e overall Kaiser-Meyer-Olkin (KMO) measure (0.89) and 
the individual KMO measures (all greater than 0.7) showed the adequacy of sampling, and the 
Bartlett’s test of sphericity was statistically signifi cant (p<0.005), thus the inhibitory data was 
suitable for PCA. In PCA, only one component with an eigenvalue greater than one was revealed, 
and this component explained 85.1% of the total variance. 
In the correlation tests, only negative correlations were found between the diff erent 
properties, and all of them were relatively weak. Th e PCA values of the antimicrobial activity tests 
correlated negatively with the averaged adhesion (Spearman’s rho -0.346, p=0.001), indicating 
that the strains showing the highest adhesion ability generally exhibited lower inhibitory capacity 
of the indicator pathogens. To some extent, this was also illustrated when comparing the largest 
identifi cation groups (see 5.2.2 and 5.2.4). Additionally, the PCA values correlated negatively 
with the tolerance towards pH 2 (Spearman’s rho -0.519, p<0.0005) as well as with the tolerance 
toeards pH 4 (Spearman’s rho -0.220, p=0.034). Th us, those strains with the greatest ability to 
inhibit the growth of the indicator pathogens generally seemed to show lower tolerance towards 
low pH. 
5.2.6 S? mula? on of cytokine produc? on by dendri? c cells (IV)
Th e possible stimulation of immune signaling in human MoDCs by the L. amylovorus strains 
was assessed at three diff erent bacterial concentrations. Induction of cytokine production was 
observed at the bacteria/DC ratio of 100:1, with substantial strain-dependent diff erences between 
the levels of cytokines induced (Fig. 5 in IV). Th e cytokine profi les induced by the strains were not 
clearly skewed towards Th 1 or Th 2 phenotypes. Instead, a mixed type of response, including Th 1 
favoring (IL-12), Th 2 favoring (IL-10) as well as proinfl ammatory (TNF-α, IL-6, IL-1β, IP-10/
CXCL10) cytokines, was stimulated by most of the strains. Similar cytokine profi les have been 
demonstrated also for L. gasseri strains (Luongo et al., 2013), while induction of proinfl ammatory 
cytokine profi les without high IL-12 expression has also been described for some strains of this 
Lactobacillus species (Stoeker et al., 2011). Interestingly, the strain NCFM of L. acidophilus, 
which is a close relative of L. amylovorus, has been shown to stimulate the diff erentiation of 
human DCs towards Th 2 generation via interaction between the SlpA protein and the DC-SIGN 
molecule (dendritic cell specifi c C-type lectin intercellular adhesion molecule 3-grabbing non-
integrin) (Konstantinov et al., 2008b). Although the SlpA proteins of the L. amylovorus strains 
used in this study show a high similarity with the NCFM SlpA (Additional fi le 2 in IV), the Th 2 
favoring action of NCFM was not observed with the present L. amylovorus strains. On the other 
hand, a skewing towards Th 1 type has also been observed to be caused by L. acidophilus NCFM 
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in both murine BMDCs (Weiss et al., 2010) and human MoDCs (Gad et al., 2011), emphasizing 
the divergent eff ects observed for the same strains with diff erent experimental designs.
By using diff erent bacterial doses in DC stimulation experiments, a clear dose-dependent 
eff ect has been observed (Smits et al., 2005; Konstantinov et al., 2008b; Gad et al., 2011). 
For example, the ratio of IL-10 to IL-12 can even be reversed with increasing bacterial loads 
(Konstantinov et al., 2008b). Smits et al. (2005) observed optimal in vitro priming of regulatory 
DCs cells with MOI values of 1, whereas higher concentrations of bacteria evoked lower eff ect. 
Th is contrasts with the results of the present study, in which no notable induction of any of 
the cytokines measured was observed at the lower MOI values of 10 and 1, as compared to the 
negative control (data not shown).
5.2.7 An? bio? c suscep? bility (III)
To evaluate if antibiotics could be used as selective agents in the bacterial culture of porcine fecal 
samples in Study III, the susceptibilities of the strains used in the feeding trial to fi ve antibiotics 
was tested with the broth microdilution method (Table 8). All of the strains were sensitive to 
G-penicillin, which seems to be a common feature among lactobacilli (Klare et al., 2007; Nawaz 
et al., 2011; Gueimonde et al., 2013). Four strains expressed resistance towards vancomycin, 
concurring with previous results obtained for human and food isolates (Klare et al., 2007; Nawaz 
et al., 2011) and also with the fact that many species of lactobacilli are intrinsically resistant to 
this antibiotic (Saarela et al., 2000; Gueimonde et al., 2013). Similarly, lactobacilli oft en exhibit 
resistance towards inhibitors of nucleic acid synthesis, such as fl uoroquinolones (Karapetkov et 
al., 2011; Gueimonde et al., 2013), and this was also the case for the porcine strains examined 
in this study, although the MIC values were somewhat variable. Th e most extensive variation 
was observed in the susceptibility of the strains to kanamycin and tobramycin; previously the 
resistance of lactobacilli isolated from diff erent food and animal sources towards aminoglycosides 
(i.e. gentamycin, tobramycin and kanamycin) has also been described to be variable (Nawaz et 
al., 2011; Bujnakova et al., 2014; Klose et al., 2014).  No single antibiotic, which could have been 
used as a selective agent for isolation of the six strains from the porcine fecal samples, could be 
identifi ed amongst the tested antibiotic agents. 
Table 8. Minimal inhibitory concentration (MIC) values (μg/ml) of the Lactobacillus strains for 
selected antibiotics assayed using microdilution method, with two parallel wells for each dilution 
series of the antibiotics. 
Strain Penicillin G Enrofl oxacin Kanamycin Tobramycin Vancomycin
L. mucosae GLR 1167 <0.125 16 32 8 512
L. salivarius GRL 1169 <0.125 2 256 64 >1024
L. johnsonii GRL 1171 <0.125 32 256 128 <8
L. reuteri GRL 1168 <0.125 16 32 128 512
L. reuteri GRL 1170 <0.125 8 64 8 512
L. amylovorus GRL 1112 <0.125 8 64 64 <8
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5.3 In vivo feeding trial (II, III)
5.3.1 Animal performance and growth (II, III)
During the adaptation period, signs of mild diarrhea were recorded in some of the piglets, and a 
total of seven piglets (three in both the control and multispecies supplementation groups and one 
in the L. brevis group) had to be treated with the combination of trimethoprim and sulfadiazine 
(Tribrissen, Schering-Plough A/S, Denmark). On the other hand, all piglets remained healthy 
during the actual feeding trial, exhibiting no clinical signs of diarrhea or any other adverse eff ects. 
When evaluating the possible benefi cial health eff ects of bacterial feed supplements in 
meat-producing animals, weight gain during the feeding trial is a commonly used measure, as 
improved growth would be highly desirable outcome of probiotic supplementation. In swine, 
enhanced growth rates have been observed both with monostrain (Abe et al., 1995; Guerra et 
al., 2007) and multistrain/-species (Choi et al., 2011a; Choi et al., 2011b) supplementations. 
On the other hand, a failure to promote growth has also been reported with both types of 
supplementation (Shim et al., 2005; Mair et al., 2010a). In the present study, no statistically 
signifi cant diff erences in the mean body weight (BW) or ADWG could be detected between the 
control and the two supplementation groups at any of the measurement points, although piglets 
receiving L. brevis supplementation had a numerically greater fi nal body weight than the piglets 
in the other two groups (Table 9). Th is concurs with an earlier study, in which a diff erent L. 
brevis strain (1E1) also induced a statistically non-signifi cant growth increase in neonatal piglets 
(Gebert et al., 2011). Th e high variability in growth promotion observed aft er various bacterial 
supplementations can be attributed to several factors, e.g. inherent characteristics of the species 
or strain being used. Additionally, host-specifi c properties like age and health status can aff ect 
the responses of the host to bacterial supplementation (Taras et al., 2007; Gaggia et al., 2010). 
Furthermore, it has been speculated that the hygienic conditions in experimental institutes may 
be too favorable to allow the appearance of any clear health benefi ts or growth promotion aft er 
bacterial supplementation, as the environmental pathogen load in these sites is presumably lower 
compared to that present in commercial intensive rearing units (Simon et al., 2001). 
Table 9. Eff ects of a monostrain (L. brevis) and a multistrain Lactobacillus supplementations on the 

























0.12 6.5 ± 0.2 6.6 ± 0.2 5.9 ± 0.2 6.1 ± 0.2
p-value1 0.627 0.619 0.415 0.967 0.237 0.642 0.779
1 P-values for Kruskall-Wallis test
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5.3.2 Detec? on of the supplemented strains in the intes? ne and feces (II, III)
To investigate the survivability of the strains fed to the piglets, bacterial colonies isolated from the 
fecal samples were analyzed with species-specifi c PCR (II, III). A total of 144 colonies (56 from 
the L. brevis group and 44 from the control and multispecies groups, respectively) were analyzed 
by L. brevis S-layer specifi c PCR; however, no positive results were found. On the other hand, 
each of the bacterial species included in the multispecies formulation was found among the fecal 
isolates analyzed (44 colonies from both the control and multispecies supplementation groups) 
(Table 3 in III). However, in PFGE, none of the strains isolated from the supplementation group 
fecal samples had an identical SmaI pattern (genotype) to the strains which had been fed to the 
piglets, even though one L. reuteri isolate from the slaughter sample did resemble L. reuteri GRL 
1170 (Fig. 9). 
Th is inability to isolate any of the strains fed to the piglets from the fecal samples was 
unexpected and surprising. Previously, using a similar technique, the same L. brevis strain that 
was used in the present trial was isolated from human stool samples in a small-scale intervention 
study (Rönkä et al., 2003), and as well from feces of mice that had received the strain via an oral 
gavage (unpublished data from the laboratory of A. Palva). In addition, the Lactobacillus strains 
included in the multispecies supplementation had all been originally isolated from the intestine 
and feces of swine, and based on the in vitro screening tests for tolerance of low pH and bile 
it was expected that the strains would be able to survive in the porcine GI-tract. However, as 
the bacterial culturing method used with the pooled fecal samples may have lacked suffi  cient 
sensitivity to detect the strains, it cannot be concluded with certainty that the supplemented 
strains were unable to survive passage through the intestine of swine. Previously, certain 
Lactobacillus strains have been observed to survive transit through the GI tract of pigs (Table 3), 
but high variability have been observed in the excretion levels of the strain fed between diff erent 
host individuals (Gardiner et al., 2004). 
To investigate the distribution of L. brevis cells in the porcine intestine in more detail, the 
presence of this strain in the intestinal lumen and mucosa of the piglets from the control and L. 
brevis supplementation groups was examined with real-time qPCR analysis of the digesta and 
fecal samples as well as with histological examination of cryosections using IFA (II). With both 
of these methods, L. brevis was found as the most abundant in the large intestine of piglets from 
the L. brevis supplementation group. In this group, genomic DNA of L. brevis was detected in 
the cecal digesta of four piglets as well as in the colonic digesta and feces of seven piglets while 
only one piglet from the control group had any detectable amounts of L. brevis DNA in its cecum 
(Fig. 1 in II). Th e inability to detect L. brevis in every piglet of the supplementation group may be 
due to the detection limit of the real-time qPCR assay (104 genomes g-1) or host-related genetic 
factors infl uencing the ability of the strain to colonize the intestinal microbiota. On the other 
hand, when examining the cecal and colonic cryosections, L. brevis-like cells were detected in 
samples from every piglet in the supplementation group and with high cell numbers, but accurate 
and reliable enumeration of individual cells was problematic owing to the large cell clusters that 
had formed (Fig. 2 in II). In addition, nonspecifi c staining of smaller-sized bacterial cells further 
complicated L. brevis cell counting; thus, numerical data for the large intestine cryosections is 
not presented. In the small intestine, genomic DNA of L. brevis was not found in the digesta of 
either the control or the supplementation group (<104 genomes g-1). However, L. brevis-like cells 
were detected in the jejunal and ileal cryosections from both groups, with the jejunum sections 
of the supplementation group displaying statistically signifi cantly higher cell numbers compared 
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to the control group (Mann-Whitney U-test p<0.001), while no diff erence was observed in the 
ileum (Fig. 3 in II). Taken together, the results of the real-time qPCR analysis of the digesta 
and detection L. brevis-like cells with intact cell morphology in cryosections suggest that this 
strain may be capable of colonizing both the large, and to a lesser extent also the small, intestines 
of weaned piglets. However, the viability of the strain in the piglet intestine should be further 
confi rmed.
Interestingly, potentially indigenous L. brevis cells were also detected in a few control group 
piglets both in cryosections (with L. brevis SlpA-specifi c antiserum), as well as in the large 
intestinal digesta samples (with real-time qPCR). While this Lactobacillus species does not seem 
to be a prominent member of the porcine gut microbiota (Hill et al., 2002; Leser et al., 2002; Hill 
et al., 2005), it has been isolated previously from diff erent porcine samples (Krause et al., 1995; 
Martin et al., 2009; Gebert et al., 2011; Qi et al., 2011), thus the L. brevis-like cells detected in 
samples from the control group were in all likelihood indigenous strains of this Lactobacillus.
In an attempt to examine whether the L. brevis strain used would adhere more effi  ciently to 
Peyer’s patches as compared to the regular intestinal wall areas, the small intestinal cryosections 
containing and not containing Peyer’s patches were examined for the presence of L. brevis-like 























L. reuteri GRL 1168 
L. reuteri GRL 1170 
Figure 9. Dendrogram representing the Dice coeffi  cient-derived percentages of similarity 
among the distinct SmaI PFGE patterns obtained for fecal L. reuteri isolates. Th e source 
of isolates is listed on the right. C=control group; F=multispecies supplementation group; 
0=sample taken before the start of the trial; S=sample taken at slaughter.
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adhere specifi cally to Peyer’s patches (Perdigon et al., 2000; Plant and Conway, 2001; Edelman et 
al., 2002), the mucosal numbers of L. brevis-like cells were similar in both types of cryosections 
(Fig. 3 in II), suggesting that this strain lacks the capacity to adhere specifi cally to these tissue 
structures.
5.3.3 E? ects of the supplementa? ons on the bacterial and lactobacillar counts 
(II, III)
In order to reveal any major eff ects of the bacterial supplements on the GI-tract microbiota, the 
total numbers of bacteria (II, III) and lactobacilli (III) were quantifi ed with real-time qPCR. While 
increased numbers of digestal or fecal lactobacilli and / or other bacterial species considered 
benefi cial for the host have been detected in some previous porcine feeding trials (Pollmann et 
al., 1980; De Angelis et al., 2007; Choi et al., 2011b), the multispecies supplementation used in 
the present study did not infl uence the abundance of lactobacilli in either the intestinal contents 
or feces of the piglets (Fig. 2 in III). However, increased numbers of total bacteria were detected 
in the jejunum of the multispecies supplementation group, as compared to the control group 
(Mann-Whitney U-test p=0.023; Fig. 2 in III), suggesting that some changes had occurred in the 
indigenous microbiota of this intestinal compartment due to the multispecies supplementation. 
In the L. brevis supplementation group, the quantities of bacteria remained similar to the control 
group in all intestinal compartments investigated (Table 2 in II), which is in agreement with a 
previous porcine feeding trial performed with L. amylovorus DSM 16698T (Konstantinov et al., 
2008a).
5.3.4 Immunological e? ects of the supplementa? ons (II, III)
To determine whether the L. brevis supplement could induce systemic humoral immune 
responses, total IgA and IgG as well as L. brevis-specifi c IgG concentrations were measured from 
serum samples of the L. brevis and the control group (II). While in both groups the concentrations 
of serum IgA and IgG increased during the feeding trial, no statistically signifi cant diff erences 
could be observed between the groups (Fig. 5 in II). Additionally, the levels of L. brevis-specifi c 
IgG remained similar in both groups (data not shown). Th ese results indicate that the L. brevis 
strain used does not elicit a measurable humoral immune response, or alternatively, that the 
length of the bacterial supplementation was too short to induce any detectable antibody response. 
Th e detection of L. brevis-specifi c IgG antibodies in piglets from the control group is likely due to 
either cross-reactivity or the stimulation of antibody production by an autochthonous L. brevis 
strain. Correspondingly, the presence of serum IgA antibodies that recognize L. rhamnosus GG, 
considered an atypical bacterium of the porcine microbiota, has been demonstrated also in 
piglets that did not receive this strain as a feed supplement (Casini et al., 2007). Furthermore, 
IgA antibodies able to recognize L. amylovorus DSM 16698T have been detected in both the 
supplementation and control groups (Konstantinov et al., 2008a), thus in swine it seems that 
it may be rather common to detect cross-reactive antibodies binding to various Lactobacillus 
species.
Th e potential eff ects of the L. brevis supplement on the expression of selected immunological 
genes were fi rst screened by investigating the intestinal mucosal samples of fi ve piglets from the 
L. brevis and the control groups by real-time qPCR (data not shown). However, as the RNA 
extracted from the samples was of low quality and quantity, an alternative method, QuantiGene 
2.0 Plex Assay (Aff ymetrix/Panomics, USA), permitting mRNA quantitation without RNA 
extraction, was used for the analysis of the mucosal samples. 
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Examination of the gene expression of eight cytokines (i.e. IL-1β, IL-4, IL-6, IL-8, TGF-
β1, IFN-α, IFN-γ and TNF) in the intestinal mucosa revealed that although both types of 
supplementations did induce some alterations in the expression of these cytokines, more 
pronounced eff ects were triggered by the multispecies preparation  (Fig. 4 in II; Fig. 3 in III). 
Th e mRNA levels of the cytokine TGF-β1 were downregulated in the ileum by both of the 
supplementations (Mann-Whitney U test p=0.015 (L. brevis group) and <0.001 (multispecies 
group)), and also in the jejunum (p<0.001) and the colon (p=0.017) by the multispecies 
formulation. Th is contrasts to previous results obtained for another type of multispecies 
supplementation containing four bacterial strains which exerted no eff ect on the expression 
of this cytokine in the intestine of weaned piglets (Mair et al., 2010b). Moreover, increased 
production of TGF- β1 in the Caco-2 cell line has been reported aft er contact with gut 
commensals, including Lactobacillus strains (Zeuthen et al., 2008). Despite the downregulation 
of the anti-infl ammatory TGF-β1 cytokine, no visual changes were observed in the pathological 
investigation of the porcine intestinal walls, suggesting that the supplementations had not 
induced any infl ammation in the intestinal wall.
Interestingly, the mRNA levels of the cytokines IL-6 and IL-4 were upregulated in the cecum 
by both types of supplementation (Fig. 4 in II; Fig. 3 III), although statistical signifi cance was 
reached only by the IL-4 change in the multispecies group (p=0.035) and the IL-6 change in 
the L. brevis group (p=0.023). While changes in the expression of IL-6 in the small intestinal 
mucosa of piglets have been reported to occur e.g. during weaning (Pie et al., 2004) as well as 
aft er bacterial supplementation (Zhang et al., 2011; Deng et al., 2013), there does not seem to be 
any data available on the expression patterns of this cytokine in the colon of piglets. With regard 
to the increased cecal mRNA expression of IL-4 stimulated by the multispecies supplementation, 
this change was mainly attributable to two individual piglets in that group, and when the Mann-
Whitney U test analysis was performed without these piglets, no diff erence between the groups 
was any longer apparent (data not shown). However, no special features were observed in the 
pathological investigation of the cecum wall samples from these two individuals. It does seem 
that the intestinal expression of this major Th 2 cytokine has not been investigated in other 
bacterial feeding studies performed in swine, and little is known about the function of IL-4 in 
the porcine intestine. In human intestinal cell lines, IL-4 has been found to reduce the barrier 
function of the epithelial monolayer, resulting in its increased permeability to macromolecules 
(Colgan et al., 1994; Berin et al., 1999). However, there are indications that species diff erences 
exist in the expression and functions of IL-4 (Reddy et al., 2000; Raymond and Wilkie, 2004; 
Bautista et al., 2007), and diff erences between swine breeds have been observed (Verfaillie et 
al., 2001; de Groot et al., 2005), refl ecting possible genetic factors infl uencing immune function. 
Th us, the functions of IL-4 in the porcine intestine remain to be explored in further studies. 
In addition to the increased mRNA expression of IL-4, also the mRNA expression of IFN-α 
was upregulated in the cecum of the multispecies supplementation group (p=0.001). While the 
production of interferons has traditionally been considered to be primarily induced by viruses, 
also bacteria, including lactobacilli, are known to stimulate their production (Kitazawa et al., 
1994; Bogdan et al., 2004). 
In the colon, the multispecies formulation induced a downregulated mRNA expressions of 
IL-8 (p=0.008) and TNF (p=0.001). Previously, a fi ve-strain bacterial supplementation has been 
reported to increase the expression of IL-8 in the ileum of weaned piglets, but the large intestinal 
compartments were not investigated (Walsh et al., 2008).  In addition, the expression of TNF in 
the colon and the small intestine of weaned piglets was not altered by a four-strain supplement 
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(Mair et al., 2010b). Th ese dissimilarities in the results of various studies are probably due to 
diff erences in the bacterial strains used, as well as in the experimental designs, such as the 
genetic background of the animals, as these factors can aff ect the results of immunological 
studies (Joling et al., 1993; de Groot et al., 2005; Flori et al., 2011). One limitation of the present 
study was the heterogeneity of the study population, as the piglets represented a mixture of 
diff erent breeds as well as genders, and this may well have exerted an infl uence on the outcomes. 
Moreover, when considering the complexity of the mucosal immune system, it is very diffi  cult 
to draw any fi rm conclusions about the results from cytokine expression studies, as is predicting 
what would be the concrete health consequences of increased or decreased gene expression of 
diff erent cytokines triggered by bacterial supplementation. Consequently, reasonable speculation 
on these phenomena will need to be based on more detailed information about the immune 
system networks.
5.4 The surface layer proteins of Lactobacillus amylovorus strains (IV)
5.4.1 Genomic characteriza? on and expression analysis of L. amylovorus 
S-layer proteins (IV)
In the in silico analysis of the L. amylovorus genomes, several slp genes were revealed in each of 
the strains. Th e presence of multiple S-layer protein genes is common in lactobacilli, and has 
previously been reported e.g. in strains of L. acidophilus (Boot et al., 1995) as well as those closely 
related to L. acidophilus, including L. amylovorus (Boot et al., 1996b), and also in strains of L. 
brevis (Jakava-Viljanen et al., 2002) and L. crispatus (Sillanpää et al., 2000). Th e L. amylovorus 
slp genes with high homology to L. acidophilus NCFM slpA and slpB (Konstantinov et al., 2008b) 
were also named slpA and slpB, respectively, and the third type of slp-like gene detected was 
designated slpC. For both slpA and slpB, most of the strains carried only one gene homologue, but 
two distinct homologues of slpA and slpB were detected in GRL 1117 and DSM20531, respectively. 
Th ere was more variation in the number of slpC-type genes, as one to three homologues were 
recognized in the L. amylovorus strains (Fig. 6 in IV). A phylogenetic tree constructed based 
on the deduced amino acid sequences of the slpA, slpB and slpC gene products indicated that 
the SlpA-like sequences have diversifi ed most during the evolution, while the SlpB-type proteins 
have remained more similar to each other and the predicted SlpC-type proteins have formed 
three distinct groups (Fig. 6 in IV, the deduced amino acid sequences of the L. amylovorus Slp 
proteins are presented in Additional fi le 1 in IV).
Comparison of the sequence data of the slp genes with the results of the aminoterminal 
sequencing or the peptide mapping analysis performed for the L. amylovorus S-layer proteins 
revealed that the major S-layer protein bands seen in the surface protein profi les of the strains 
(Fig. 7 in IV) were all encoded by slpA-like genes. Th e amino acid sequences of the SlpA proteins 
were found to be very similar to that of the L. acidophilus NCFM SlpA protein, especially in the 
carboxy terminal region. Th is may refl ect the role of the C-terminal part in cell wall binding, 
previously described in L. acidophilus (Smit et al., 2001) and L. crispatus (Antikainen et al., 
2002). Bands representing the products of slpB- and slpC-like genes were also identifi ed in the 
surface protein profi les of the strains: the former in strains GRL 1117 and DSM 16698 but the 
latter only in strain DSM 16698 (Fig. 7 in IV). While multiple S-layer genes are commonly 
carried by lactobacilli, simultaneous expression of more than one of these gene seems rare, but 
this phenomenon has been previously described for L. brevis ATCC 14869 (Jakava-Viljanen et 
al., 2002) and L. acidophilus NCMF (Goh et al., 2009).
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5.4.2 The role of L. amylovorus S-layer proteins in adherence (IV)
To explore if the L. amylovorus S-layer proteins have a role in the adherence capacity of the 
strains to IPEC-1 cells, a protein presentation system based on the propensity of S-layer proteins 
to recrystallize in a native manner on purifi ed CWF was developed (an electron micrograph of 
purifi ed CWF: Fig. 8B in IV). In an attempt to minimize the presence of Slp protein aggregates 
in the adhesion assay, the dilute Slp protein fraction was separated from the precipitated 
protein by centrifugation, as has been described previously (Åvall-Jääskeläinen et al., 2008). 
Th e method applied to the purifi cation of the CWF preserves the covalently attached polymeric 
components like teichoic acids and polysaccharides, which ensures the proper self-assembly 
of the recombinant Slp:s and leads to the presentation of the S-layer proteins in the native and 
symmetric organization observed on the surface of bacterial cells. In the adhesion assays, the 
detection of the Slp-coated CWF was performed with an indirect immunofl uorescence staining 
using Slp-specifi c antibodies. Uncoated CWF were used as negative controls, but as attempts to 
produce functional antibodies against purifi ed cell wall fragments were unsuccessful, these were 
biotinylated prior to the adhesion assay, and detected with labeled streptavidin aft er the assay. 
While none of the uncoated CWF adhered to the IPEC-1 cells, at least a low level of 
adherence was demonstrated for all of the Slp coated CWF. However, the adherence level of 
the coated CWF did not correlate to that of the bacterial strain from which the proteins had 
originated. For example, the adhesion of CWF coated with SlpA from the strains DSM 16698 
(Fig. 8D in IV), GRL 1112 or GRL 1115 was poor, even though the intact cells of these strains 
were adhesive to IPEC-1 cells (Fig. 2 in IV). On the other hand, the CWF coated with Slp:s from 
the weakly adhering strains GRL 1117 (Fig. 8H in IV), DSM 20531T (Fig. 8G in IV) and GRL 
1118  did display affi  nity for IPEC-1 cells. Th e SlpB of the strain DSM 16698 as well showed some 
adhesiveness (Fig. 8E in IV), when compared to SlpA (Fig. 8D in IV) or SlpC (Fig. 8F in IV) of 
the same strain. 
Th ese results indicate that none of the L. amylovorus S-layer proteins examined in this 
study solely mediate adhesion of the strains to IPEC-1 cells. However, also other non-covalently 
attached cell wall components may have been removed during the preparation of the CWF, and 
that these structures may well have a role in the mediation of adherence. Th is methodological 
limitation also applies to experiments based on chemical extraction of the S-layer from the 
bacterial surface; while this procedure has been shown to decrease the adhesion of lactobacilli 
to diff erent targets (Hynönen and Palva, 2013), providing indirect evidence that the S-layer 
structure is involved in the adhesion process, a role for other non-covalently attached molecules 
removed in the extraction process cannot be excluded.
Th e highly effi  cient binding of the S-layer protein originating from the weakly adhesive 
strain GRL 1117 indicates that some component(s) on the surface of this strain shield(s) the 
S-layer and thus prevents the adhesion of the strain to IPEC-1 cells. Th is kind of phenomenon 
has been observed in L. rhamnosus GG: the exopolysaccharide component shields the mucus-
binding fi mbriae, reducing the adhesive capacity of the strain for mucus (Kankainen et al., 2009; 
Lebeer et al., 2009). While genes putatively participating in exopolysaccharide synthesis have 
been identifi ed in all of the L. amylovorus strains studied (unpublished data from the laboratory 
of A. Palva), no biochemical evidence of their presence has been described so far. Th us, the 
reason for reduced adhesiveness of the intact cells of GRL 1117 compared to that of the SlpA-
protein originating from this strain remains to be explained.
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6 Conclusions and future aspects
Th e importance of the gut microbiota to the health and well-being of the host has been 
increasingly recognized during the last decade, and the use of microbial supplements to 
modulate the composition and function of this complex community has generated much interest 
in the fi elds of human and veterinary medicine. While various types of microbial products have 
been used in production animals, including swine, to maintain and improve the health and 
productivity of the host animal, several factors related to the selection process of the microbes 
as well as the functional mechanisms behind the observed eff ects still remain unrevealed. Th us, 
comprehensive studies regarding the use of probiotic microbes on various animal species are 
warranted. Th e main aim of this study was to characterize the probiotic potential of porcine 
lactobacilli for use in swine production. In addition, as lactobacillar S-layers are attractive 
candidates for antigen carriers in vaccine vectors, strains of lactobacilli possessing an S-layer 
were also investigated in this work.
I. Th e in vitro screening assays for selected traits commonly considered important for a 
putative probiotic led to the following conclusions:
1) the probiotic properties of porcine LAB strains, such as acid and bile 
tolerance, adherence to host structures, ability to inhibit pathogens as well as 
immunostimulatory patterns vary considerably, even between strains of the same 
species. Th is fi nding emphasizes the need for careful selection of the putative 
probiotic strain,
2) the porcine LAB isolates examined in this study generally adhered more effi  ciently 
to large intestinal enterocytes, in comparison to those collected from the small 
intestine. While the isolation site of the strain did not aff ect its adhesion preferences 
towards enterocytes of diff erent origins, this may be infl uenced by the fact that the 
strains were isolated from intestinal digesta, and it would be interesting to explore 
this aspect also with strains originating from the mucosa of diff erent intestinal 
sections, 
3) the ability to inhibit pathogen adhesion was not strictly correlated with the adhesive 
capacity of the porcine Lactobacillus strain. Th us, in addition to competition for 
the same adhesion sites, also other mechanisms are involved in the inhibition of 
pathogen adhesion, 
4) while the SCF of the LAB isolates inhibited the growth of several pathogens, this 
inhibition was mainly due to low pH value of the fi ltrate. However, some of the 
isolates seemed to produce also other inhibitory compounds, but the nature of these 
substances remains to be investigated in future studies and 
5) some of the properties correlated negatively with each other; for example, LAB 
strains showing high adhesion ability to enterocytes generally exhibited lower 
ability to inhibit pathogen growth. Although these correlations were only weak, this 
fi nding may indicate that it may be diffi  cult to discover strain(s) that would possess 
all the characteristics considered desirable for probiotic bacteria. Indeed, no single 
strain showing excellent performance in all of the diff erent properties tested in this 
work was detected. 
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II. Th e in vivo feeding trial led to the following conclusions:
1) both of the supplementations used (i.e. a monostrain preparation containing 
L. brevis ATCC 8287, and a multistrain preparation containing six lactobacilli of 
porcine origins) were well tolerated by piglets, and produced no adverse eff ects. Th e 
supplementations did not seem to exert any growth enhancing eff ects; however, this 
aspect needs to be explored in more detail in clinically relevant settings, 
2) both supplementations induced some alterations of cytokine mRNA expression 
in the intestinal mucosa, with more pronounced changes being produced by 
the multistrain preparation, especially in the large intestinal area. Despite these 
immunological alterations in the intestinal mucosa, neither of the supplementations 
caused mucosal infl ammation. Th e health consequences of these changes in 
mucosal cytokine expression will need to be clarifi ed in future studies,
3) the supplemented strains may not be able to survive transit through the swine 
GI-tract; however, as the method used may have lacked suffi  cient sensitivity, the gut 
transit tolerance of these strains will need to be investigated further in more detail. 
Nevertheless, it seems probable that these strains are not able to effi  ciently compete 
with the indigenous gut microbiota of weaned piglets. In future studies, it would be 
interesting to investigate the ability of these strains to colonize and / or to survive 
passage through the GI-tract of suckling piglets, and 
4) both of the supplementations examined in this work may be suitable for use as 
probiotics in swine, but as the effi  cacy of these putative probiotics under intensive 
production systems cannot be evaluated based on these preliminary results, more 
comprehensive studies will still be needed to assess their possible eff ects on porcine 
health and immunity. Additionally, the potential use of the L. brevis strain as a 
vaccine carrier for swine pathogens is worthy of further investigations e.g. with 
immunization studies performed using a recombinant strain expressing suitable 
antigens, such as the receptor binding domain of the FedF adhesin of F18+ E. coli 
strains causing oedema disease and / or weaning diarrhea.
 
III. Th e genomic characterization of the S-layer protein-carrying L. amylovorus strains led to 
the following conclusions:
1) several slp –like genes are carried by each of the strains; these genes were named 
slpA, slpB and slpC. In all of the strains, the major Slp protein was encoded by 
the slpA gene, and this protein group shared high sequence similarity with the L. 
acidophilus NCFM SlpA protein. In addition to the major S-layer protein SlpA, two 
strains carried also other S-layer-like proteins on their surface, namely SlpB and / 
or SlpC and
2) as the adherence level of the CWF coated with L. amylovorus Slp proteins did not 
correlate to that of the bacterial strains from which the proteins had originated, 
it seems apparent that none of the major Slp proteins alone mediate the adhesion 
of the strain to IPEC-1 cells. However, the putative role of other non-covalently 
attached cell wall components possibly removed during the preparation of the CWF 
should be examined in further studies.
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